<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1626193</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2025.1626193</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Synergistic antibacterial photodynamic therapy of lysine-porphyrin conjugate and metal ions combination against <italic>Candida albicans</italic> and <italic>Mycobacterium tuberculosis</italic>
</article-title>
<alt-title alt-title-type="left-running-head">Wang et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2025.1626193">10.3389/fphar.2025.1626193</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wang</surname>
<given-names>Xueming</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2301898/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Qin</surname>
<given-names>Zhonghua</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wen</surname>
<given-names>Ying</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chi</surname>
<given-names>Mingxuan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3072287/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Lixia</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2016542/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Junping</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Liu</surname>
<given-names>Tianjun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>State Key Laboratory of Advanced Medical Materials and Devices</institution>, <institution>Tianjin Key Laboratory of Biomedical Materials</institution>, <institution>Institute of Biomedical Engineering</institution>, <institution>Chinese Academy of Medical Science and Peking Union Medical College</institution>, <addr-line>Tianjin</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Tuberculosis Precision Testing Center</institution>, <institution>Tianjin Haihe Hospital</institution>, <addr-line>Tianjin</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/544179/overview">Tingting Zhao</ext-link>, China-Japan Friendship Hospital, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2543588/overview">Mine G&#xfc;l &#x15e;eker</ext-link>, Gebze Technical University, T&#xfc;rkiye</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/781340/overview">Dianlei Wang</ext-link>, Anhui University of Chinese Medicine, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2908592/overview">Suparata Kiartivich</ext-link>, Krirk University, Thailand</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Tianjun Liu, <email>liutianjun@hotmail.com</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>31</day>
<month>07</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1626193</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>05</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>06</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Wang, Qin, Wen, Chi, Zhang, Wu and Liu.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Wang, Qin, Wen, Chi, Zhang, Wu and Liu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>In previous research, antibacterial photodynamic therapy using lysine-porphyrin conjugate LD<sub>4</sub> effectively inactivated methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli; however, it exhibited limited activity against Candida albicans and Mycobacterium tuberculosis.</p>
</sec>
<sec>
<title>Methods</title>
<p>To address this limitation, we developed a synergistic antibacterial strategy by combining LD<sub>4</sub> with Cu<sup>2&#x002B;</sup> or Zn<sup>2&#x002B;</sup>.</p>
</sec>
<sec>
<title>Results</title>
<p>Synergy was confirmed via minimum inhibitory concentration and fractional inhibitory concentration index analyses, demonstrating 16- to 64-fold enhanced antibacterial efficacy compared to LD<sub>4</sub> alone. Mechanistic studies revealed divergent pathways for LD<sub>4</sub> &#x002B; Cu<sup>2&#x002B;</sup> and LD<sub>4</sub> &#x002B; Zn<sup>2&#x002B;</sup>: Zn<sup>2&#x002B;</sup> increased the reactive oxygen species yield and promoted LD4 uptake by pathogens, while LD<sub>4</sub> &#x002B; Cu<sup>2&#x002B;</sup> induced oxidative damage to cell walls and membranes in darkness, with light exposure exacerbating structural damage. Cytotoxicity assessments confirmed low toxicity, with &#x003e;90% survival of normal cells at bactericidal concentrations. Fluorescence and infrared spectroscopy characterized metal-LD<sub>4</sub> complexes, showing stabilization through interactions between amino and pyrrolic imino groups of LD<sub>4</sub> and metal ions, which promoted non-radiative transitions and fluorescence quenching. Both combinations caused significant bacterial membrane disruption and growth suppression. Notably, cytotoxicity exhibited a biphasic dose-response linked to metal-LD<sub>4</sub> complexation-dependent particle size changes.</p>
</sec>
<sec>
<title>Discussion</title>
<p>This study elucidated the enhanced antimicrobial mechanisms and safety of LD<sub>4</sub>-metal ion combinations. The findings resolve the limitations of LD<sub>4</sub> while providing a theoretical framework for developing novel therapies against fungal and mycobacterial infections.</p>
</sec>
</abstract>
<kwd-group>
<kwd>antibacterial photodynamic therapy</kwd>
<kwd>lysine-conjugated porphyrin compound</kwd>
<kwd>metal ions</kwd>
<kwd>synergistic antibacterial therapy</kwd>
<kwd>
<italic>Candida albicans</italic>
</kwd>
<kwd>
<italic>Mycobacterium tuberculosis</italic>
</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Experimental Pharmacology and Drug Discovery</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Microbial infections have become a major threat to global public health, particularly due to the dual pressures of nosocomial infections and the rapid emergence and spread of drug-resistant bacteria, which pose unprecedented challenges to human health. According to data from the <xref ref-type="bibr" rid="B31">World Health Organization (2014)</xref> and various national health institutions (<xref ref-type="bibr" rid="B6">Collaborators, 2022</xref>), key pathogens responsible for widespread epidemics include <italic>Streptococcus pneumoniae</italic> (<xref ref-type="bibr" rid="B26">Mitchell and Mitchell, 2010</xref>), <italic>Mycobacterium tuberculosis</italic> (<italic>Mtb</italic>) (<xref ref-type="bibr" rid="B40">Sia and Rengarajan, 2019</xref>), methicillin-resistant <italic>Staphylococcus aureus</italic> (<xref ref-type="bibr" rid="B22">Li et al., 2012</xref>), and <italic>Escherichia coli</italic> (<italic>E. coli</italic>) (<xref ref-type="bibr" rid="B30">Oordt-Speets et al., 2018</xref>). Annually, bacterial infections result in an estimated six to eight million deaths globally (<xref ref-type="bibr" rid="B7">Collaborators, 2017</xref>), while fungal infections account for approximately 3.75 million fatalities. Projections indicate that by 2050, these figures could reach 10 million deaths annually (<xref ref-type="bibr" rid="B15">Ikuta et al., 2024</xref>; <xref ref-type="bibr" rid="B31">Organization, 2014</xref>). Antibiotics function by targeting essential processes for bacterial growth through diverse mechanisms and are indispensable for treating bacterial infections (<xref ref-type="bibr" rid="B31">Organization, 2014</xref>). However, the current mainstream antibacterial treatment regimens are characterized by significant limitations (<xref ref-type="bibr" rid="B2">Baran et al., 2023</xref>). For instance, despite the ability of antibiotics to achieve efficient bactericidal effects through specific targets, such as penicillin-binding proteins (<xref ref-type="bibr" rid="B52">Zapun et al., 2008</xref>) and ribosomes (<xref ref-type="bibr" rid="B46">Wilson, 2014</xref>), treatment with these agents is challenged by the rapid evolution of drug resistance, which far outpaces the new drug development cycle (<xref ref-type="bibr" rid="B8">Cook and Wright, 2022</xref>). The widespread overuse and misuse of antibiotics (<xref ref-type="bibr" rid="B43">Timmerhuis et al., 2023</xref>; <xref ref-type="bibr" rid="B1">Aggarwal et al., 2024</xref>), despite decades of rigorous pharmacological investigation, have precipitated a critical public health crisis: accelerated evolution of antibiotic resistance in bacterial and fungal pathogens (<xref ref-type="bibr" rid="B4">Blair et al., 2015</xref>). This situation arises primarily from selection pressures driving genetic mutations within microbial populations, which in turn foster rapid pathogen adaptation through horizontal gene transfer and efflux pump upregulation (<xref ref-type="bibr" rid="B24">Ma et al., 2023</xref>). Consequently, such adaptive mechanisms diminish the clinical efficacy of existing antimicrobial agents and create a self-reinforcing cycle wherein resistance development outpaces the discovery and deployment of novel antibiotics, thereby threatening the long-term viability of antimicrobial drug pipelines. In resource-constrained settings, social and economic barriers significantly hinder access to effective antibiotics (<xref ref-type="bibr" rid="B16">Iskandar et al., 2021</xref>). Moreover, their efficacy is often restricted in treating biofilm-associated chronic infections, including chronic wound infections and implant-related infections (<xref ref-type="bibr" rid="B39">Sharma et al., 2016</xref>). Furthermore, metal-based antibacterial materials (<xref ref-type="bibr" rid="B50">Yang et al., 2022</xref>), such as silver (<xref ref-type="bibr" rid="B51">Yin et al., 2020</xref>), zinc (<xref ref-type="bibr" rid="B35">Riduan and Zhang, 2021</xref>), and copper ions (<xref ref-type="bibr" rid="B27">Mitra et al., 2020</xref>), have garnered attention for their broad-spectrum antibacterial properties and relatively low potential to induce drug resistance (<xref ref-type="bibr" rid="B34">Ren et al., 2022</xref>). Nevertheless, their clinical application is hindered by dose-dependent cytotoxicity and the potential risk of spreading metal resistance genes, such as <italic>silE</italic> (<xref ref-type="bibr" rid="B29">Monneau et al., 2023</xref>) and <italic>copA</italic> (<xref ref-type="bibr" rid="B23">Li et al., 2023</xref>). Considering these dual constraints&#x2014;dose-dependent cytotoxicity compromising therapeutic windows and horizontal transfer of resistance genes&#x2014;novel combinatorial strategies leveraging photodynamic therapy (PDT) show unique promise. Particularly, porphyrin-based photosensitizers like LD4 offer distinct advantages: their innate metal-chelating capacity enables formation of stable complexes that sequester toxic free ions (reducing systemic exposure), while simultaneous ROS generation disrupts bacterial membranes through physical oxidation, circumventing conventional resistance mechanisms (<xref ref-type="bibr" rid="B49">Xu et al., 2016</xref>). Therefore, there is an urgent need to develop novel antibacterial strategies to effectively address this challenge. In this context, innovative material designs like Zn-Cu-In-S/ZnS-mTHPP conjugates emerge as promising alternatives. As recently demonstrated, such quantum dot-porphyrin hybrids not only enhance photodynamic tumor cell killing by 72% but also exhibit inherent light-independent antibacterial activity against pathogens including <italic>E. coli</italic>&#x2014;offering dual therapeutic modalities that bypass traditional cytotoxicity and resistance limitations(<xref ref-type="bibr" rid="B44">Tsolekile et al., 2022</xref>).</p>
<p>Antibacterial photodynamic therapy (aPDT) is a novel physical and chemical bacterial inactivation technology based on photosensitizers (<xref ref-type="bibr" rid="B28">M&#xf8;ller et al., 2005</xref>). It physically kills bacteria through the burst of reactive oxygen species (ROS) mediated by photosensitizers (<xref ref-type="bibr" rid="B17">Jiang et al., 2024</xref>). Its mechanism of action can bypass traditional drug resistance barriers, providing a new solution for overcoming the dormancy of persister cells, biofilm encapsulation, and drug penetration obstacles (<xref ref-type="bibr" rid="B48">Wu et al., 2023</xref>). The three key elements of aPDT are photosensitizers, oxygen, and light (<xref ref-type="bibr" rid="B9">Correia et al., 2021</xref>). As the core component, the structural differences of photosensitizers determine their therapeutic effects on different disease indications. However, the use of aPDT against certain pathogens is subject to several limitations. These challenges include the risk of systemic toxicity caused by cationic photosensitizers, the potential for light-induced damage to surrounding healthy tissues, the limited light penetration in deep tissues, the decreased effectiveness against persistent bacteria, and the lack of a standardized evaluation framework (<xref ref-type="bibr" rid="B33">Puttaswamy et al., 2023</xref>). In our previous studies, we synthesized a series of amino acid-conjugated porphyrins and conducted detailed structural characterizations of these compounds (<xref ref-type="bibr" rid="B25">Meng et al., 2015</xref>). A systematic evaluation of their antimicrobial activities was also conducted. We found that compound LD<sub>4</sub> exhibited promising aPDT effects against methicillin-resistant <italic>Staphylococcus aureus</italic>, <italic>Pseudomonas aeruginosa</italic>, and <italic>E. coli</italic>. The underlying mechanism involves the generation of ROS upon light activation, which induces bacterial oxidative stress responses (<xref ref-type="bibr" rid="B49">Xu et al., 2016</xref>). However, LD<sub>4</sub> exhibits relatively weak antibacterial activity against <italic>Mtb</italic> and <italic>Candida albicans</italic> (<italic>C. albicans</italic>) (minimum inhibitory concentration [MIC] &#x3e;125&#xa0;&#x3bc;g/mL), primarily due to the low uptake efficiency of LD<sub>4</sub> by these pathogens. Notably, in addition to its aPDT effect, LD<sub>4</sub> significantly enhances the intracellular levels of metal ions such as Cu<sup>2&#x2b;</sup> in bacteria. Based on these findings, in this study, we investigated a combination therapeutic strategy involving exogenous supplementation of metal ions (e.g., Cu<sup>2&#x2b;</sup>, Zn<sup>2&#x2b;</sup>) synergistically with LD<sub>4</sub> to broaden the antibacterial spectrum of LD<sub>4</sub> and address its limited efficacy against certain pathogens. We propose that Cu<sup>2&#x2b;</sup>/Zn<sup>2&#x2b;</sup> enhances LD<sub>4</sub>&#x2019;s membrane affinity or ROS generation via complexation.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Materials</title>
<p>Copper sulfate pentahydrate (CuSO<sub>4</sub>&#xb7;5H<sub>2</sub>O), zinc acetate [Zn(OAc)<sub>2</sub>], ferric chloride hexahydrate (FeCl<sub>3</sub>&#xb7;6H<sub>2</sub>O), magnesium Sulfate (MgSO<sub>4</sub>), manganous acetate [Mn(OAc)<sub>2</sub>], chloroform, 3-morpholino-2-propanesulfonic acid, benzylsulfanilimide F, potassium bromide (KBr), disodium ethylenediaminetetraacetate, MeOH, dimethyl formamide, dimethyl sulfoxide (DMSO), 2,7-dichlorofluorescein diacetate (DCFH-DA), and 50% glutaraldehyde were purchased from Bide Pharmaceutical Technology Co., Ltd. (Shanghai, China). Lysozyme (egg white) was purchased from Shanghai Yuanye Bio-Technology Co., Ltd. (Shanghai, China). Cell Counting Kit-8 (CCK-8) was obtained from Biosharp Biotechnology Co., Ltd. (Beijing China). Middlebrook 7H9 broth medium and modified Lowenstein - Jensen medium base were obtained from Signature Biotechnology Co., Ltd. (Guangzhou, China). Sabouraud&#x2019;s medium was obtained from Beijing Solarbio Technology Co., Ltd. (Beijing, China). LD<sub>4</sub> was synthesized as previously described (<xref ref-type="bibr" rid="B25">Meng et al., 2015</xref>). The standard strain of <italic>Mtb</italic> H37Rv, the drug-sensitive strain 63, 64 and the drug-resistant strain 22,26 (resistant to rifampicin and isoniazid) were provided by the Tianjin Haihe Hospital (Tianjin, China). Ethical approval for the utilization of clinical strains was obtained from the Tianjin Haihe Hospital Medical Ethics Committee (Approval No. 2024HHQX-002). Mouse fibroblasts (3T3), human immortalized keratinocytes (HaCaT), human normal liver cells (LO2), and human bronchial epithelial cells (BEAS-2B) were obtained from Wuhan Pricella Biotechnology Co., Ltd. (Wuhan, China). Semiconductor laser (model 7404, Intense, North Brunswick, NJ, United States) and optical power meter (LM1; Carl Zeiss, Oberkochen, Germany) were used.</p>
</sec>
<sec id="s2-2">
<title>2.2 Determining MIC and minimum bactericidal concentration, and synergy assessment for metal ions and LD<sub>4</sub>
</title>
<p>For <italic>C. albicans</italic> and <italic>Mtb</italic>, the MIC was determined using the broth microdilution method. Serial two-fold dilutions of metal ions solution were prepared in Sabouraud&#x2019;s or Middlebrook 7H9 broth medium, and LD<sub>4</sub> was prepared in phosphate-buffered saline, ranging from 1,000&#x2013;1.95&#xa0;&#x3bc;g/mL. <italic>C. albicans</italic> strains were grown to the logarithmic phase and then adjusted to a standard inoculum density. The <italic>Mtb</italic> was inoculated onto the modified L&#xf6;wenstein - Jensen medium and incubated at 37&#xb0;C in a constant temperature incubator. After approximately 4 weeks of incubation, the culture reached the logarithmic growth phase. Subsequently, the <italic>Mtb</italic> colonies were harvested from the medium by scraping and resuspended in 2&#xa0;mL of normal saline. Next, the bacterial suspension was sonicated for 120&#xa0;s to ensure uniform dispersion. A bacterial concentration equivalent to 1 McFarland standard (approximately 3 &#xd7; 10<sup>8</sup>&#xa0;CFU/mL) was achieved and subsequently diluted to 10<sup>5</sup>&#xa0;CFU for further experiments. Aliquots of the bacterial suspension (100&#xa0;&#x3bc;L) were added to each well of the 96-well microdilution plate containing the metal ions or LD<sub>4</sub> concentrations (100&#xa0;&#x3bc;L). For <italic>C. albicans</italic>, the fungal suspension and drug solution were co-incubated for 30&#xa0;min; in contrast, for <italic>Mtb</italic>, the bacterial suspension and drug solution were co-incubated for 24&#xa0;h. The plates were exposed to a 650&#xa0;nm laser with an energy density of 6&#xa0;J/cm<sup>2</sup> for 10&#xa0;min and subsequently incubated at 37&#xb0;C for either 24&#xa0;h or 2&#xa0;weeks, depending on the organism. The MIC was defined as the lowest concentration of the test compound that completely inhibited visible bacterial growth after incubation. The minimum bactericidal concentration was determined following the MIC assay. For <italic>C. albicans</italic> and <italic>Mtb</italic>, suspensions from wells showing no visible growth (i.e., at or above the MIC) were subcultured onto sterile Sabouraud&#x2019;s agar or Lowenstein - Jensen medium plates, respectively. These plates were then incubated under the same conditions used for the respective MIC assays. The minimum bactericidal concentration was defined as the lowest concentration of the test compound that resulted in no visible growth on the agar plates, indicating a reduction in viable bacteria or fungi by at least 99.9% compared to the untreated control.</p>
<p>The antimicrobial synergistic effects of metal ions and LD<sub>4</sub> were evaluated against the bacterial strains <italic>C. albicans</italic> and <italic>Mtb</italic> using the Checkerboard dilution method. Serial concentrations of metal ions and LD<sub>4</sub> were prepared to achieve final concentrations of 4MIC, 2MIC, MIC, 1/2MIC, 1/4MIC, 1/8MIC, 1/16MIC, and 0 in the respective wells of a 96-well microdilution plate.</p>
<p>The fractional inhibitory concentration index (FICI) for each drug in combination was calculated using the following formulas (<xref ref-type="bibr" rid="B3">Barbara et al., 2006</xref>):<disp-formula id="equ1">
<mml:math id="m1">
<mml:mrow>
<mml:mtext mathvariant="bold">FICI</mml:mtext>
<mml:mo>&#x3d;</mml:mo>
<mml:msub>
<mml:mtext mathvariant="bold">FIC</mml:mtext>
<mml:mrow>
<mml:mtext mathvariant="bold">metal</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext mathvariant="bold">ions</mml:mtext>
</mml:mrow>
</mml:msub>
<mml:mo>&#x2b;</mml:mo>
<mml:msub>
<mml:mtext mathvariant="bold">FIC</mml:mtext>
<mml:msub>
<mml:mtext mathvariant="bold">LD</mml:mtext>
<mml:mn mathvariant="bold">4</mml:mn>
</mml:msub>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mtext mathvariant="bold">MIC</mml:mtext>
<mml:mrow>
<mml:mtext mathvariant="bold">metal</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext mathvariant="bold">ions</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext mathvariant="bold">in</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext mathvariant="bold">combination</mml:mtext>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mtext mathvariant="bold">MIC</mml:mtext>
<mml:mrow>
<mml:mtext mathvariant="bold">metal</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext mathvariant="bold">ion</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext mathvariant="bold">independently</mml:mtext>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#x2b;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mtext mathvariant="bold">MIC</mml:mtext>
<mml:mrow>
<mml:msub>
<mml:mtext mathvariant="bold">LD</mml:mtext>
<mml:mn mathvariant="bold">4</mml:mn>
</mml:msub>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext mathvariant="bold">in</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext mathvariant="bold">combination</mml:mtext>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mtext mathvariant="bold">MIC</mml:mtext>
<mml:mrow>
<mml:msub>
<mml:mtext mathvariant="bold">LD</mml:mtext>
<mml:mn mathvariant="bold">4</mml:mn>
</mml:msub>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext mathvariant="bold">independently</mml:mtext>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
<p>Synergistic effects were defined as FICI &#x2264; 0.5, additive effects as 0.5 &#x3c; FICI &#x2264; 1, indifferent effects as 1 &#x3c; FICI &#x2264; 4, and antagonistic effects as FICI &#x3e; 4.</p>
</sec>
<sec id="s2-3">
<title>2.3 Assessment of LD<sub>4</sub> uptake by <italic>C. albicans</italic> and <italic>Mtb</italic>
</title>
<p>To investigate the synergistic mechanism of Cu<sup>2&#x2b;</sup>/Zn<sup>2&#x2b;</sup> and LD<sub>4</sub> against <italic>C. albicans</italic> and H37Rv, the intracellular uptake of LD<sub>4</sub> was quantified using flow cytometry. H37Rv was cultured on L&#xf6;wenstein - Jensen medium at 37&#xb0;C until the logarithmic growth phase. Bacterial colonies were harvested using sterile loops, suspended in normal saline, and homogenized by ultrasonication (5&#xa0;s pulse/5&#xa0;s pause, 12 cycles, 80% amplitude) to obtain a uniform suspension (5 McFarland standard). <italic>C. albicans</italic> was cultured on Sabouraud&#x2019;s medium at 28&#xb0;C until the logarithmic growth phase, and the suspension was concentrated to 5 McFarland standard. Three experimental groups were established: LD<sub>4</sub> alone (31.25&#xa0;&#x3bc;g/mL); LD<sub>4</sub> (31.25&#xa0;&#x3bc;g/mL) &#x2b; Cu<sup>2&#x2b;</sup>; and LD<sub>4</sub> (31.25&#xa0;&#x3bc;g/mL) &#x2b; Zn<sup>2&#x2b;</sup>. Metal ion concentrations ranged from 3.13 to 50&#xa0;&#x3bc;g/mL (two-fold serial dilution). For each condition, 1&#xa0;mL of bacterial suspension was mixed with 500&#xa0;&#x3bc;L of LD<sub>4</sub> (125&#xa0;&#x3bc;g/mL stock solution) and 500&#xa0;&#x3bc;L of metal ion solution in sterile tubes. After incubation for 24&#xa0;h in the dark at 37&#xb0;C, unbound LD<sub>4</sub> was removed by centrifugation (4,000 &#xd7; <italic>g</italic>, 10&#xa0;min, 4&#xb0;C), and the bacteria were subsequently washed thrice with saline (0.9% NaCl, Signature Biotechnology Co., Ltd. ,Guangzhou, China). Washed bacteria were resuspended in 1&#xa0;mL saline, filtered through a 40&#xa0;&#x3bc;m cell strainer, and analyzed using a NovoCyte Quanteon flow cytometer (Agilent Technologies Inc. ,City of Santa Clara, CA, United States). PE-Cy7 channel (excitation/emission: 488/780&#xa0;nm) was selected based on LD<sub>4</sub> fluorescence. Data from 100,000 events per sample were acquired at high flow rate (66&#xa0;&#x3bc;L/min), with unstained bacteria serving as negative controls. Fluorescence compensation was applied using single-stained LD<sub>4</sub> samples. Three independent replicate experiments were conducted for each group.</p>
</sec>
<sec id="s2-4">
<title>2.4 Determination of fluorescence and infrared spectra for metal ions in combination with LD<sub>4</sub>
</title>
<p>A stock solution of LD<sub>4</sub> (10&#xa0;mg/mL) was prepared in DMSO. Metal ion stock solutions (Zn<sup>2&#x2b;</sup> and Cu<sup>2&#x2b;</sup>) were prepared at concentration of 2,000&#xa0;ppm (weight/volume) in ultrapure water. Three experimental groups were designed to evaluate quenching effects: Control group with LD<sub>4</sub> alone (31.25&#xa0;&#x3bc;g/mL); LD<sub>4</sub> &#x2b; metal ions (31.25&#xa0;&#x3bc;g/mL LD<sub>4</sub> &#x2b; 50&#xa0;&#x3bc;g/mL combined Zn<sup>2&#x2b;</sup> or Cu<sup>2&#x2b;</sup>). Aliquots of diluted metal ions (500&#xa0;&#x3bc;L) and LD<sub>4</sub> working solution (500&#xa0;&#x3bc;L) were mixed in 2&#xa0;mL microcentrifuge tubes, followed by incubation at 25&#xb0;C for 10&#xa0;min. Temperature-dependent experiments were conducted at 20&#xb0;C, 10&#xb0;C, and 0&#xb0;C using a thermostatically controlled ethanol bath. Fluorescence spectra were acquired using a fluorescence spectrophotometer (Hitachi F4600, Japan) with excitation at 390&#xa0;nm and emission scanning from 400 to 800&#xa0;nm. Slit widths were set at 2&#xa0;nm for both excitation and emission. The Stern - Volmer equation was applied to quantify quenching efficiency:<disp-formula id="equ2">
<mml:math id="m2">
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="bold-italic">I</mml:mi>
<mml:mn mathvariant="bold">0</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:mi mathvariant="bold-italic">I</mml:mi>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#x3d;</mml:mo>
<mml:mn mathvariant="bold">1</mml:mn>
<mml:mo>&#x2b;</mml:mo>
<mml:msub>
<mml:mi mathvariant="bold-italic">K</mml:mi>
<mml:mi mathvariant="bold-italic">q</mml:mi>
</mml:msub>
<mml:msub>
<mml:mi mathvariant="bold-italic">&#x3c4;</mml:mi>
<mml:mn mathvariant="bold">0</mml:mn>
</mml:msub>
<mml:mrow>
<mml:mfenced open="[" close="]" separators="|">
<mml:mrow>
<mml:mi mathvariant="bold-italic">Q</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:math>
</disp-formula>where <italic>I</italic>
<sub>0</sub> and <italic>I</italic> represent fluorescence intensities without and with quencher, respectively; <italic>Kq</italic> is the Stern - Volmer quenching constant; <italic>&#x3c4;</italic>
<sub>0</sub> denotes the intrinsic fluorescence lifetime; and [<italic>Q</italic>] indicates quencher concentration. The quenching efficiency (<italic>&#x3b7;</italic>) was calculated using the following formula:<disp-formula id="equ3">
<mml:math id="m3">
<mml:mrow>
<mml:mi mathvariant="bold-italic">&#x3b7;</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">F</mml:mi>
<mml:mi mathvariant="bold-italic">I</mml:mi>
</mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">L</mml:mi>
<mml:mi mathvariant="bold-italic">D</mml:mi>
</mml:mrow>
<mml:mn mathvariant="bold">4</mml:mn>
</mml:msub>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">F</mml:mi>
<mml:mi mathvariant="bold-italic">I</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">L</mml:mi>
<mml:mi mathvariant="bold-italic">D</mml:mi>
</mml:mrow>
<mml:mn mathvariant="bold">4</mml:mn>
</mml:msub>
<mml:mo>&#x2b;</mml:mo>
<mml:mi mathvariant="bold-italic">i</mml:mi>
<mml:mi mathvariant="bold-italic">o</mml:mi>
<mml:mi mathvariant="bold-italic">n</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">F</mml:mi>
<mml:mi mathvariant="bold-italic">I</mml:mi>
</mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="bold-italic">L</mml:mi>
<mml:mi mathvariant="bold-italic">D</mml:mi>
</mml:mrow>
<mml:mn mathvariant="bold">4</mml:mn>
</mml:msub>
</mml:msub>
</mml:mfrac>
<mml:mo>&#xd7;</mml:mo>
<mml:mn mathvariant="bold">100</mml:mn>
<mml:mo>%</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula>where <italic>FI</italic>
<sub>
<italic>LD</italic>4</sub> and <italic>FI</italic>
<sub>
<italic>LD4&#x2b;ion</italic>
</sub> correspond to maximum fluorescence intensities of LD<sub>4</sub> in the absence and presence of metal ions, respectively.</p>
<p>Infrared spectra were acquired using a Thermo Fisher Scientific Nicolet iS20 Fourier-transform infrared (FTIR) spectrometer (Waltham, MA, United States). LD<sub>4</sub> samples were analyzed in three states: LD<sub>4</sub> alone; LD<sub>4</sub>-Cu<sup>2&#x2b;</sup> complex; and LD<sub>4</sub>-Zn<sup>2&#x2b;</sup> complex. The concentrations of LD<sub>4</sub>, Cu<sup>2&#x2b;</sup>/Zn<sup>2&#x2b;</sup> were 31.25&#xa0;&#x3bc;g/mL and 50&#xa0;&#x3bc;g/mL, respectively. The complex was prepared via freeze-drying. Each sample (5&#xa0;mg) was homogeneously mixed with anhydrous KBr (spectroscopic grade, 500&#xa0;mg) using a mortar and pestle for 15&#xa0;min under ambient conditions. The mixture was pressed into transparent pellets (10&#xa0;mm diameter) under 10&#xa0;MPa pressure for 35&#xa0;s using a hydraulic pellet press. Pellets were mounted in the sample compartment, and background spectra were collected from clean KBr crystals. FTIR measurements were performed over the wavenumber range of 400&#x2013;4,000&#xa0;cm<sup>&#x2212;1</sup> with a spectral resolution of 4&#xa0;cm<sup>&#x2212;1</sup>. Each spectrum represented the average of three independent scans to ensure reproducibility.</p>
</sec>
<sec id="s2-5">
<title>2.5 Determination of ROS yield</title>
<p>DCFH-DA was employed as the fluorescent probe for quantifying ROS production. The DCFH-DA powder was dissolved in DMSO to prepare a 10&#xa0;mM stock solution, which was aliquoted and stored at &#x2212;20&#xb0;C in the dark. During the experiment, the stock solution was diluted 1:1,000 prior to use. LD<sub>4</sub> was used at a concentration of 31.25&#xa0;&#x3bc;g/mL, while Cu<sup>2&#x2b;</sup> and Zn<sup>2&#x2b;</sup> metal ions were combined with LD<sub>4</sub> at concentrations of 50, 25, 12.5, 6.25, and 3.13&#xa0;&#x3bc;g/mL. For each experimental group, 1&#xa0;mL of solution was prepared, and 1&#xa0;&#x3bc;L of the DCFH-DA stock solution was added. After thorough mixing, the samples were exposed to a 650&#xa0;nm laser with a light density of 6&#xa0;J/cm<sup>2</sup> for 10&#xa0;min. Following irradiation, the samples were diluted three-fold, and their fluorescence intensities were measured using a fluorescence spectrometer. Change in the rate of ROS production was calculated using the following formula:<disp-formula id="equ4">
<mml:math id="m4">
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="bold-italic">R</mml:mi>
<mml:msub>
<mml:mi mathvariant="bold-italic">&#x3a6;</mml:mi>
<mml:mo>&#x394;</mml:mo>
</mml:msub>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="bold-italic">F</mml:mi>
<mml:mi mathvariant="bold-italic">s</mml:mi>
</mml:msub>
<mml:mo>&#xd7;</mml:mo>
<mml:msubsup>
<mml:mi mathvariant="bold-italic">&#x3b7;</mml:mi>
<mml:mi mathvariant="bold-italic">s</mml:mi>
<mml:mn mathvariant="bold">2</mml:mn>
</mml:msubsup>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="bold-italic">F</mml:mi>
<mml:mi mathvariant="bold-italic">r</mml:mi>
</mml:msub>
<mml:mo>&#xd7;</mml:mo>
<mml:msubsup>
<mml:mi mathvariant="bold-italic">&#x3b7;</mml:mi>
<mml:mi mathvariant="bold-italic">r</mml:mi>
<mml:mn mathvariant="bold">2</mml:mn>
</mml:msubsup>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#xd7;</mml:mo>
<mml:mn mathvariant="bold">100</mml:mn>
<mml:mo>%</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
<p>
<italic>F</italic>
<sub>
<italic>s</italic>
</sub> and <italic>F</italic>
<sub>
<italic>r</italic>
</sub> represent areas under the fluorescence curve of the sample and LD<sub>4</sub> control groups, respectively, at 525&#xa0;nm; <italic>&#x3b7;</italic>
<sub>
<italic>s</italic>
</sub> is the refractive index of the sample solution, and <italic>&#x3b7;</italic>
<sub>
<italic>r</italic>
</sub> is the refractive index of the solvent in the LD<sub>4</sub> control group.</p>
</sec>
<sec id="s2-6">
<title>2.6 Transmission electron microscopy (TEM) analysis</title>
<p>The dispersion of <italic>Mtb</italic> was performed as described in <xref ref-type="sec" rid="s2-2">Section 2.2</xref>, and a bacterial suspension with a concentration of 10 MCF was prepared. Subsequently, the suspension was transferred to a 5&#xa0;mL centrifuge tube and centrifuged at 4,000&#xa0;rpm for 10&#xa0;min. The supernatant was discarded. The stock solutions of Cu<sup>2&#x2b;</sup> and Zn<sup>2&#x2b;</sup> were diluted to a final concentration of 31.25&#xa0;&#x3bc;g/mL and added to the treated bacterial suspension. The mixture was incubated at 37&#xb0;C for 24&#xa0;h. After incubation, the samples were centrifuged again at 4,000&#xa0;rpm for 10&#xa0;min, the supernatant was discarded, and the pellets were washed thrice with 1&#xa0;mL of physiological saline under identical centrifugation conditions. Following washing, 5% glutaraldehyde solution (2&#xa0;mL) was added to each sample for fixation. The samples were thoroughly mixed and fixed at 4&#xb0;C for 72&#xa0;h. Next, the fixed samples were observed under a TEM (FEI Tecnai F20, Hillsboro, OR, United States) for morphological analysis and image acquisition. Elemental mapping signals were subsequently collected to determine the distribution characteristics of Cu<sup>2&#x2b;</sup> and Zn<sup>2&#x2b;</sup> within the bacteria.</p>
</sec>
<sec id="s2-7">
<title>2.7 Cytotoxicity of the combination of metal ions and LD<sub>4</sub>
</title>
<p>Cytotoxicity was assessed using the CCK-8 assay in various cell lines, including HaCaT, 3T3, BEAS-2B, and LO2. Concentrations for Cu<sup>2&#x2b;</sup> and Zn<sup>2&#x2b;</sup> monotherapy were set at 6.25, 12.5, 25, 50, and 100&#xa0;&#x3bc;g/mL, while those for Cu<sup>2&#x2b;</sup>/Zn<sup>2&#x2b;</sup>-LD<sub>4</sub> were set at 7.81 &#x2b; 3.13, 15.63 &#x2b; 6.25, 31.25 &#x2b; 12.5, 62.5 &#x2b; 25, and 125 &#x2b; 50&#xa0;&#x3bc;g/mL based on the FIC results. After the cells reached the logarithmic growth phase, they were co-incubated with the respective treatment at 37&#xb0;C for 30&#xa0;min and subsequently irradiated with a 650&#xa0;nm laser (energy density: 6&#xa0;J/cm<sup>2</sup>) for 10&#xa0;min. Thereafter, cells were transferred to a cell incubator and incubated for an additional 24&#xa0;h. Following incubation, enhanced CCK-8 dilution solution (10&#xa0;&#x3bc;L) was added to each well of both the experimental and control groups. The plates were then incubated at 37&#xb0;C and 5% CO<sub>2</sub> for 30&#xa0;min. Following incubation, the plates were removed, and the absorbance at 450&#xa0;nm was measured for each well using an enzyme-linked spectrophotometer (Thermo Fisher Scientific, VARIOSKAN FLASH, Waltham, MA, United States).</p>
</sec>
<sec id="s2-8">
<title>2.8 Determination of particle size of the combination of LD<sub>4</sub> and metal ion</title>
<p>The changes in particle size upon mixing LD<sub>4</sub> solution with Cu<sup>2&#x2b;</sup> and Zn<sup>2&#x2b;</sup> at specific concentrations were determined using a laser particle size analyzer (Malvern Panalytical ZETASIZER Ultra ZSU3305, Malvern, United Kingdom). Three mixed solutions were prepared with concentrations of 125 &#x2b; 50, 62.5 &#x2b; 25, and 31.25 &#x2b; 12.5&#xa0;&#x3bc;g/mL (LD<sub>4</sub> &#x2b; Cu<sup>2&#x2b;</sup>/Zn<sup>2&#x2b;</sup>), respectively. The solutions were treated with ultrasound for 15&#xa0;min to ensure homogeneity. Subsequently, the particle size changes of the mixed solutions were measured at 25&#xb0;C. Prior to each measurement, the instrument was stabilized for 2&#xa0;min to ensure measurement accuracy.</p>
</sec>
<sec id="s2-9">
<title>2.9 Statistical analysis</title>
<p>Data processing was performed using GraphPad Prism software (version 8.0.1). All experiments in this chapter were independently repeated three times. Statistical analyses were carried out using GraphPad Prism 8.0.2 software, and image processing as well as data export were conducted using ImageJ software. Results are presented as mean &#xb1; standard deviation (mean &#xb1; SD). Each variable was analyzed using one-way ANOVA, and the significance of differences between groups was assessed via Tukey&#x2019;s multiple comparison test (p &#x3c; 0.05).</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>3 Results and discussion</title>
<sec id="s3-1">
<title>3.1 Synergy assessment for metal ions and LD<sub>4</sub>
</title>
<p>The MIC values of each metal ion and LD<sub>4</sub> against <italic>C. albicans</italic> alone were determined using the broth microdilution method, providing a basis for investigating the synergistic effects between metal ions and LD<sub>4</sub>. Significant antifungal activity of Cu<sup>2&#x2b;</sup>, Zn<sup>2&#x2b;</sup>, Fe<sup>3&#x2b;</sup>, and Mn<sup>2&#x2b;</sup> against <italic>C. albicans</italic> was demonstrated, with MIC values of 40&#xa0;&#x3bc;g/mL. In contrast, Mg<sup>2&#x2b;</sup> exhibited weaker antifungal efficacy, with an MIC value of 80&#xa0;&#x3bc;g/mL. Additionally, LD<sub>4</sub> showed limited antifungal activity against <italic>C. albicans</italic>, with an MIC value of 125&#xa0;&#x3bc;g/mL. Based on the above results, we observed that the antifungal activity of certain metal ions (Cu<sup>2&#x2b;</sup>, Zn<sup>2&#x2b;</sup>, Fe<sup>3&#x2b;</sup>, and Mn<sup>2&#x2b;</sup>) was significantly higher than that of LD<sub>4</sub>. As a lysine-conjugated amino phenyl porphyrin photosensitizer, LD<sub>4</sub> had been suggested by previous studies to potentially exert synergistic effects through its ability to complex metal ions (Cu<sup>2&#x2b;</sup>) and accumulate in pathogenic microorganisms (manuscript in preparation). Based on these findings, we propose that the antifungal activity of LD<sub>4</sub> against <italic>C. albicans</italic> can be enhanced through the addition of supplementary metal ions. To verify this hypothesis, the checkerboard dilution method was used to quantitatively assessed the synergistic effect of metal ions combined with LD<sub>4</sub> against <italic>C. albicans</italic>.</p>
<p>As shown in <xref ref-type="table" rid="T1">Table 1</xref>, the metal ions with the most effective synergistic effects were Cu<sup>2&#x2b;</sup>, Zn<sup>2&#x2b;</sup>, Mn<sup>2&#x2b;</sup>, and Mg<sup>2&#x2b;</sup>, all of which had FICI values &#x3c; 0.5. Compared to their individual utilization, the MIC of these four metal ions decreased by 16- to 32-fold, while the MIC of LD<sub>4</sub> decreased by 64- to 16-fold. These results demonstrated that when combined with LD<sub>4</sub>, Cu<sup>2&#x2b;</sup>, Zn<sup>2&#x2b;</sup>, Mn<sup>2&#x2b;</sup>, and Mg<sup>2&#x2b;</sup> exhibited a significant synergistic antibacterial effect against <italic>C. albicans</italic>. The FICI value of Fe<sup>3&#x002B;</sup> was 0.75, indicating an additive effect, which was higher than those of other tested metal ions. Consequently, Cu<sup>2&#x2b;</sup>, Zn<sup>2&#x2b;</sup>, Mn<sup>2&#x2b;</sup>, and Mg<sup>2&#x2b;</sup>, which exhibited synergistic effects, were selected for further investigation of the synergistic antibacterial activity against <italic>Mtb</italic> with LD<sub>4</sub>. We selected one standard <italic>Mtb</italic> strain, two sensitive strains, and two drug-resistant strains (resistant to rifampicin and isoniazid) for this study. The results are illustrated as a heatmap (<xref ref-type="fig" rid="F1">Figure 1</xref>), while the corresponding FIC and FICI values are summarized in <xref ref-type="table" rid="T2">Table 2</xref>. The results demonstrated that Mg<sup>2&#x2b;</sup> exhibited no significant synergistic effect against <italic>Mtb</italic>, with an MIC value exceeding 50&#xa0;&#x3bc;g/mL. Furthermore, no synergistic effect was observed when Mg<sup>2&#x2b;</sup> was combined with LD<sub>4</sub>. In contrast, the combination of LD<sub>4</sub> with Cu<sup>2&#x2b;</sup>, Zn<sup>2&#x2b;</sup>, or Mn<sup>2&#x2b;</sup> resulted in pronounced growth inhibition of <italic>Mtb</italic>. Quantitative analysis demonstrated that the synergistic antibacterial effects of metal ions combined with LD<sub>4</sub> were more pronounced against sensitive strains and the standard strain H37Rv than resistant strains. The FIC values for these strains were lower than those for drug-resistant <italic>Mtb</italic>, suggesting that bacterial growth could be effectively inhibited at reduced drug combination concentrations (<xref ref-type="bibr" rid="B11">Eumkeb and Chukrathok, 2013</xref>). These three metal ions exhibited synergistic effects with LD<sub>4</sub>, with FICI values consistently &#x3c;0.5. Notably, Cu<sup>2&#x2b;</sup> and Zn<sup>2&#x2b;</sup> demonstrated the most potent synergistic efficacy against <italic>Mtb</italic> with LD<sub>4</sub>. The MIC values of these metal ions were reduced by 8- to 128-fold, while the MIC of LD<sub>4</sub> decreased by 8- to 64-fold. Furthermore, their FICI values were all &#x3c; 0.2, indicating a strong synergistic interaction. However, Mn<sup>2&#x2b;</sup> exhibited weaker synergistic effect compared to Cu<sup>2&#x2b;</sup> and Zn<sup>2&#x2b;</sup>, although it still demonstrated synergistic efficacy. FIC value of Mn<sup>2&#x2b;</sup> (25&#xa0;&#x3bc;g/mL) was higher than that of Cu<sup>2&#x2b;</sup> (0.78&#x2013;1.56&#xa0;&#x3bc;g/mL) and Zn<sup>2&#x2b;</sup> (0.78&#x2013;12.5&#xa0;&#x3bc;g/mL), and there may be a potential risk of manganese ion accumulation toxicity (<xref ref-type="bibr" rid="B36">Rodichkin and Guilarte, 2022</xref>). The concentration-dependent antibacterial activity of the LD<sub>4</sub>-Cu<sup>2&#x2b;</sup> complex highlights a critical mechanistic subtlety. Specifically, complete inhibition of <italic>Mtb</italic>. Growth was observed exclusively at the synergistic ratio of 3.91&#xa0;&#x3bc;g/mL LD<sub>4</sub> and 1.56&#xa0;&#x3bc;g/mL Cu<sup>2&#x2b;</sup> (<xref ref-type="fig" rid="F1">Figure 1</xref>, Row 1-Panel 4 and Row 2-Panel 2). Conversely, deviations from this optimal Cu<sup>2&#x2b;</sup> concentration paradoxically restored bacterial viability. This phenomenon is likely attributable to the dual interaction between the stoichiometric chelation of LD<sub>4</sub> and Cu<sup>2&#x2b;</sup> and the pathogen&#x2019;s intrinsic metal stress adaptation mechanisms. At the defined ratio, LD<sub>4</sub> and Cu<sup>2&#x2b;</sup> may form a stable antimicrobial complex that disrupts membrane integrity or metabolic pathways via targeted interactions. However, concentrations of Cu<sup>2&#x2b;</sup> could activate bacterial copper detoxification systems, such as the CtpV efflux pump (a P-type ATPase essential for copper homeostasis in <italic>Mtb.</italic>), thereby diminishing the efficacy of LD<sub>4</sub>. These adaptive responses are consistent with prior studies demonstrating mycobacterial resilience to metal stress through regulated efflux and redox balancing mechanisms (<xref ref-type="bibr" rid="B45">Ward et al., 2008</xref>). Based on these findings, Cu<sup>2&#x2b;</sup> and Zn<sup>2&#x2b;</sup> were selected for subsequent studies on mechanisms and cytotoxicity in combination with LD<sub>4</sub>.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>MIC, FIC, and FICI values of metal ions and LD<sub>4</sub> against <italic>Candida albicans</italic>.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="center">Group</th>
<th colspan="2" align="center">MIC (&#x3bc;g/mL)</th>
<th align="center">FIC (&#x3bc;g/mL)</th>
<th rowspan="2" align="center">FICI</th>
<th rowspan="2" align="center">Effect</th>
</tr>
<tr>
<th align="center">Metal ion</th>
<th align="center">LD<sub>4</sub>
</th>
<th align="center">Metal ion &#x2b; LD<sub>4</sub>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">Cu<sup>2&#x2b;</sup>
</td>
<td align="center">40</td>
<td align="center">125</td>
<td align="center">2.5 &#x2b; 1.95</td>
<td align="center">0.078</td>
<td align="center">Synergy</td>
</tr>
<tr>
<td align="center">Zn<sup>2&#x2b;</sup>
</td>
<td align="center">40</td>
<td align="center">125</td>
<td align="center">2.5 &#x2b; 0.98</td>
<td align="center">0.070</td>
<td align="center">Synergy</td>
</tr>
<tr>
<td align="center">Fe<sup>3&#x2b;</sup>
</td>
<td align="center">40</td>
<td align="center">125</td>
<td align="center">10 &#x2b; 62.5</td>
<td align="center">0.75</td>
<td align="center">Additive</td>
</tr>
<tr>
<td align="center">Mn<sup>2&#x2b;</sup>
</td>
<td align="center">40</td>
<td align="center">125</td>
<td align="center">2.5 &#x2b; 3.91</td>
<td align="center">0.16</td>
<td align="center">Synergy</td>
</tr>
<tr>
<td align="center">Mg<sup>2&#x2b;</sup>
</td>
<td align="center">80</td>
<td align="center">125</td>
<td align="center">2.5 &#x2b; 15.63</td>
<td align="center">0.094</td>
<td align="center">Synergy</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Effect represents the synergistic situation between metal ions and LD<sub>4</sub>.</p>
</fn>
<fn>
<p>Abbreviations: FIC, fractional inhibitory concentration; FICI, fractional inhibitory concentration index; MIC, minimum inhibitory concentration.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>The synergistic effect of LD<sub>4</sub> in combined with metal ions against <italic>Mycobacterium tuberculosis</italic> (<italic>Mtb</italic>) (H37Rv, 63, 64, 22, 26). Red and blue wells indicate the presence and absence of bacterial growth, respectively.</p>
</caption>
<graphic xlink:href="fphar-16-1626193-g001.tif">
<alt-text content-type="machine-generated">Grid of heatmaps showing bacterial growth versus no growth for various metal ion concentrations. Rows represent Cu&#x00b2;&#x207a;, Zn&#x00b2;&#x207a;, Mg&#x00b2;&#x207a;, and Mn&#x00b2;&#x207a;; columns reflect different strains: H37Rv, 63, 64, 22, 26. Blue indicates no growth, while red shows bacterial growth. Growth patterns vary based on metal and strain.</alt-text>
</graphic>
</fig>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>MIC, FIC, and FICI values of metal ions and LD<sub>4</sub> against <italic>Mtb</italic> (H37Rv, 63, 64, 22, 26).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="center">Strain</th>
<th rowspan="2" align="center">Group</th>
<th colspan="2" align="center">MIC (&#x3bc;g/mL)</th>
<th align="center">FIC (&#x3bc;g/mL)</th>
<th rowspan="2" align="center">FICI</th>
<th rowspan="2" align="center">Effect</th>
</tr>
<tr>
<th align="center">Metal ion</th>
<th align="center">LD<sub>4</sub>
</th>
<th align="center">Metal ion &#x2b; LD<sub>4</sub>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="4" align="center">H37Rv</td>
<td align="center">Cu<sup>2&#x2b;</sup>
</td>
<td align="center">12.5</td>
<td rowspan="4" align="center">&#x3e;125</td>
<td align="center">1.56 &#x2b; 1.95</td>
<td align="center">&#x3c;0.14</td>
<td align="center">Synergy</td>
</tr>
<tr>
<td align="center">Zn<sup>2&#x2b;</sup>
</td>
<td align="center">100</td>
<td align="center">12.5 &#x2b; 3.91</td>
<td align="center">&#x3c;0.16</td>
<td align="center">Synergy</td>
</tr>
<tr>
<td align="center">Mn<sup>2&#x2b;</sup>
</td>
<td align="center">&#x3e;100</td>
<td align="center">25 &#x2b; 1.95</td>
<td align="center">&#x3c;0.27</td>
<td align="center">Synergy</td>
</tr>
<tr>
<td align="center">Mg<sup>2&#x2b;</sup>
</td>
<td align="center">&#x3e;100</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td rowspan="4" align="center">63</td>
<td align="center">Cu<sup>2&#x2b;</sup>
</td>
<td align="center">12.5</td>
<td rowspan="4" align="center">&#x3e;125</td>
<td align="center">0.78 &#x2b; 7.81</td>
<td align="center">&#x3c;0.13</td>
<td align="center">Synergy</td>
</tr>
<tr>
<td align="center">Zn<sup>2&#x2b;</sup>
</td>
<td align="center">100</td>
<td align="center">0.78 &#x2b; 15.63</td>
<td align="center">&#x3c;0.13</td>
<td align="center">Synergy</td>
</tr>
<tr>
<td align="center">Mn<sup>2&#x2b;</sup>
</td>
<td align="center">&#x3e;100</td>
<td align="center">3.13 &#x2b; 15.63</td>
<td align="center">&#x3c;0.16</td>
<td align="center">Synergy</td>
</tr>
<tr>
<td align="center">Mg<sup>2&#x2b;</sup>
</td>
<td align="center">&#x3e;100</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td rowspan="4" align="center">64</td>
<td align="center">Cu<sup>2&#x2b;</sup>
</td>
<td align="center">12.5</td>
<td rowspan="4" align="center">&#x3e;125</td>
<td align="center">1.56 &#x2b; 3.91</td>
<td align="center">&#x3c;0.16</td>
<td align="center">Synergy</td>
</tr>
<tr>
<td align="center">Zn<sup>2&#x2b;</sup>
</td>
<td align="center">100</td>
<td align="center">1.56 &#x2b; 3.91</td>
<td align="center">&#x3c;0.05</td>
<td align="center">Synergy</td>
</tr>
<tr>
<td align="center">Mn<sup>2&#x2b;</sup>
</td>
<td align="center">&#x3e;100</td>
<td align="center">6.25 &#x2b; 15.63</td>
<td align="center">&#x3c;0.19</td>
<td align="center">Synergy</td>
</tr>
<tr>
<td align="center">Mg<sup>2&#x2b;</sup>
</td>
<td align="center">&#x3e;100</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td rowspan="4" align="center">22</td>
<td align="center">Cu<sup>2&#x2b;</sup>
</td>
<td align="center">12.5</td>
<td rowspan="4" align="center">&#x3e;125</td>
<td align="center">1.56 &#x2b; 7.81</td>
<td align="center">&#x3c;0.19</td>
<td align="center">Synergy</td>
</tr>
<tr>
<td align="center">Zn<sup>2&#x2b;</sup>
</td>
<td align="center">100</td>
<td align="center">3.13 &#x2b; 15.63</td>
<td align="center">&#x3c;0.16</td>
<td align="center">Synergy</td>
</tr>
<tr>
<td align="center">Mn<sup>2&#x2b;</sup>
</td>
<td align="center">&#x3e;100</td>
<td align="center">6.25 &#x2b; 0.49</td>
<td align="center">&#x3c;0.07</td>
<td align="center">Synergy</td>
</tr>
<tr>
<td align="center">Mg<sup>2&#x2b;</sup>
</td>
<td align="center">&#x3e;100</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="left"/>
</tr>
<tr>
<td rowspan="4" align="center">26</td>
<td align="center">Cu<sup>2&#x2b;</sup>
</td>
<td align="center">12.5</td>
<td rowspan="4" align="center">&#x3e;125</td>
<td align="center">1.56 &#x2b; 0.49</td>
<td align="center">&#x3c;0.13</td>
<td align="center">Synergy</td>
</tr>
<tr>
<td align="center">Zn<sup>2&#x2b;</sup>
</td>
<td align="center">100</td>
<td align="center">12.5 &#x2b; 1.95</td>
<td align="center">&#x3c;0.16</td>
<td align="center">Synergy</td>
</tr>
<tr>
<td align="center">Mn<sup>2&#x2b;</sup>
</td>
<td align="center">&#x3e;100</td>
<td align="center">25 &#x2b; 3.91</td>
<td align="center">&#x3c;0.28</td>
<td align="center">Synergy</td>
</tr>
<tr>
<td align="center">Mg<sup>2&#x2b;</sup>
</td>
<td align="center">&#x3e;100</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Effect represents the synergistic situation between metal ions and LD<sub>4</sub>.</p>
</fn>
<fn>
<p>Abbreviations: FIC, fractional inhibitory concentration; FICI, fractional inhibitory concentration index; MIC, minimum inhibitory concentration; <italic>Mtb</italic>, <italic>Mycobacterium tuberculosis</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-2">
<title>3.2 Uptake of LD<sub>4</sub> in <italic>C. albicans</italic> and <italic>Mtb</italic>
</title>
<p>The uptake of LD<sub>4</sub> by <italic>C. albicans</italic> and <italic>Mtb</italic> was quantitatively analyzed using flow cytometry, with fluorescence intensity serving as the indicator (<xref ref-type="bibr" rid="B38">Setiawati et al., 2017</xref>). The results are presented in <xref ref-type="fig" rid="F2">Figures 2A,B</xref>. Compared to the LD<sub>4</sub> alone group, the fluorescence intensity in the LD<sub>4</sub>&#x2b;Cu<sup>2&#x2b;</sup> group was significantly reduced (p &#x3c; 0.05). Although the fluorescence intensity in the LD<sub>4</sub>&#x2b;Zn<sup>2&#x2b;</sup> group was higher than that in the LD<sub>4</sub>&#x2b;Cu<sup>2&#x2b;</sup> group, no significant difference was observed compared to the LD<sub>4</sub> alone group (p &#x3e; 0.05). Notably, although Cu<sup>2&#x2b;</sup> and Zn<sup>2&#x2b;</sup> significantly enhanced the antibacterial efficacy of LD<sub>4</sub> against <italic>C. albicans</italic> and <italic>Mtb</italic>, this improvement did not correlate with drug uptake. The possible reason for this observation is the presence of a complexation-dissociation equilibrium between metal ions and LD<sub>4</sub> (<xref ref-type="bibr" rid="B41">Tabata et al., 1996</xref>). Consequently, the system comprises at least three components, namely, metal ions, LD<sub>4</sub>, and their complexes. These constituents exhibit distinct modes of bacterial interaction, resulting in different biological outcomes. LD<sub>4</sub> initially binds to the cell wall and partial cytoplasmic membrane of <italic>Mtb</italic>. It disrupts copper transport proteins by photodynamic action, thereby facilitating massive influx of copper ions into the bacterial cells. This process culminates in intracellular copper overload, exerting toxicity and achieving bactericidal effects. Meanwhile, the excessive accumulation of copper ions disrupts bacterial homeostasis significantly, potentially leading to bacterial death. LD<sub>4</sub> enters bacterial cells via passive diffusion at a relatively low concentration. LD<sub>4</sub> may bind to the DNA of <italic>Mtb</italic>, disrupting protein synthesis through photodynamic action, which in turn suppresses replication and inhibits bacterial growth. Copper ions may complex with the LD<sub>4</sub> porphyrin ring, leading to fluorescence quenching of LD<sub>4</sub> and promoting its aggregation. Consequently, lower fluorescence intensity of LD<sub>4</sub> is observed in flow cytometry analysis.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Measurement of LD<sub>4</sub> uptake by <italic>Mtb</italic> and <italic>C. albicans</italic> under the co-culture conditions of Cu<sup>2&#x2b;</sup>/Zn<sup>2&#x2b;</sup>. LD<sub>4</sub> uptake measurement in <bold>(A)</bold> <italic>C. albicans</italic> and <bold>(B)</bold> <italic>Mtb</italic>. <bold>(C)</bold> Flow cytometry scatter plots and histograms showing LD<sub>4</sub> uptake by H37Rv under treatment with LD<sub>4</sub>, LD<sub>4</sub> &#x2b; Cu<sup>2&#x2b;</sup>, and LD<sub>4</sub> &#x2b; Zn<sup>2&#x2b;</sup>. LD<sub>4</sub> binding levels in H37Rv cells and their contents before and after lysis in the <bold>(D)</bold> LD<sub>4</sub> &#x2b; Cu<sup>2&#x2b;</sup> group and <bold>(E)</bold> LD<sub>4</sub> &#x2b; Zn<sup>2&#x2b;</sup> group. Lysis(&#x2212;) and Lysis(&#x2b;) indicate unlysed and lysed bacterial groups, respectively. &#x2a;: p &#x3c; 0.05; &#x2a;&#x2a;: p &#x3c; 0.01; &#x2a;&#x2a;&#x2a;: p &#x3c; 0.001. Abbreviations: <italic>C. albicans</italic>, <italic>Candida albicans</italic>; <italic>Mtb</italic>, <italic>Mycobacterium tuberculosis</italic>.</p>
</caption>
<graphic xlink:href="fphar-16-1626193-g002.tif">
<alt-text content-type="machine-generated">Bar graphs and scatter plots compare the effects of copper and zinc ions on *C. albicans* and *Mtb*. Graphs A and B show fluorescence intensity versus ion concentration. Graph C includes flow cytometry scatter plots for different conditions, with or without cell lysis. Graphs D and E show mean fluorescence intensity for copper and zinc ions at varying concentrations, indicating significant differences with asterisks.</alt-text>
</graphic>
</fig>
<p>To further investigate the underlying causes of this phenomenon, we lysed <italic>Mtb</italic> that had been treated with drugs and analyzed the resulting data using flow cytometry. The scatter plots, histograms, and the fluorescence intensities before and after lysis, are presented in <xref ref-type="fig" rid="F2">Figures 2C&#x2013;E</xref>. Significant differences were observed in the bacterial scatter plots before and after lysis. The scatter points predominantly shifted toward smaller volume and increased surface roughness, confirming the success of the lysis process (<xref ref-type="bibr" rid="B12">Gienger et al., 2019</xref>). Notably, bacterial morphology changes in the LD<sub>4</sub> combined with Cu<sup>2&#x2b;</sup> and Zn<sup>2&#x2b;</sup> group were more pronounced compared to the LD<sub>4</sub> group, indicating a greater lysis effect. These findings suggest that the synergy between metal ions and LD<sub>4</sub> exerts a substantial impact on bacterial homeostasis, reducing their ability to resist external damage and rendering them more susceptible to lysis. After bacterial lysis, the supernatants were colorless, suggesting that most of the LD<sub>4</sub> was bound to the cell wall, cell membrane, and intracellular components of <italic>Mtb</italic>; only a small proportion of LD<sub>4</sub> remained in a free and unbound state. Analysis of lysed <italic>Mtb</italic> following treatment with LD<sub>4</sub> alone showed a greater release of cellular components but reduced average fluorescence intensity. This evidence indicates that, compared to the other two groups, less LD<sub>4</sub> was bound to the bacterial contents. In contrast, in the LD<sub>4</sub> &#x2b; Cu<sup>2&#x2b;</sup> group, lysis resulted in both an increased proportion of cellular contents and a significantly elevated average fluorescence intensity. These findings suggest that under metal ion co-catalysis conditions, <italic>Mtb</italic> exhibits enhanced LD<sub>4</sub> uptake capability and effectively transports LD<sub>4</sub> from the cell wall into the bacterial interior, thereby achieving efficient photodynamic antibacterial effects. When the concentration of metal ions reached 50&#xa0;&#x3bc;g/mL, the fluorescence intensity peaked, which may be closely associated with the transport mechanisms of <italic>Mtb</italic>. In the Zn<sup>2&#x2b;</sup> group, a significant difference in LD<sub>4</sub> uptake was observed between pre- and post-lysis conditions. Under high-concentration conditions (25&#xa0;&#x3bc;g/mL and 50&#xa0;&#x3bc;g/mL), the average fluorescence intensity of LD<sub>4</sub> was significantly increased, indicating that leaked bacterial contents effectively bound to LD<sub>4</sub>, enabling the exertion of the aPDT effect within bacteria. Conversely, under low-concentration conditions (3.13, 6.25, and 12.5&#xa0;&#x3bc;g/mL), the LD<sub>4</sub> content decreased after lysis, suggesting that the binding capacity of bacterial contents to LD<sub>4</sub> was lower compared to that recorded under high-concentration conditions. Additionally, in the LD<sub>4</sub> group, the fluorescence intensity was significantly decreased, further supporting the aforementioned findings. The experimental results demonstrated that the synergistic interaction of Cu<sup>2&#x2b;</sup>/Zn<sup>2&#x2b;</sup> with LD<sub>4</sub> enhances the uptake of LD<sub>4</sub> by <italic>Mtb</italic>, thereby significantly improving its antibacterial efficacy.</p>
</sec>
<sec id="s3-3">
<title>3.3 Fluorescence and infrared spectra for metal ions in combination with LD<sub>4</sub>
</title>
<p>Based on the above findings, we systematically investigated the spectral properties of the complexes formed between metal ions (Cu<sup>2&#x2b;</sup> and Zn<sup>2&#x2b;</sup>) and LD<sub>4</sub> by analyzing their fluorescence and infrared spectra at various temperatures following combined administration. The corresponding results are presented in <xref ref-type="fig" rid="F3">Figures 3A&#x2013;D</xref>. Both Zn<sup>2&#x2b;</sup> and Cu<sup>2&#x2b;</sup> induced fluorescence quenching of LD<sub>4</sub> under varying temperature conditions. Notably, Cu<sup>2&#x2b;</sup> exhibited the most pronounced quenching effect on LD<sub>4</sub> (<xref ref-type="bibr" rid="B47">Wu et al., 2020</xref>). At 20&#xb0;C, the fluorescence quenching efficiency (&#x3b7;) was &#x3e;95%. With decreasing temperature, the fluorescence quenching effect progressively intensified, reaching &#x3e;98% at 0&#xb0;C. At 0&#xb0;C, Zn<sup>2&#x2b;</sup> induced an enhancement in the fluorescence intensity of LD<sub>4</sub>. With increasing temperature, the &#x3b7; progressively increased from 18.148% to 71.628%. The fluorescence intensity of the LD<sub>4</sub> &#x2b; Cu<sup>2&#x2b;</sup> group decreased as temperature increased, from 98.823% to 95.437%. In the LD<sub>4</sub> &#x2b; Zn<sup>2&#x2b;</sup> group, the fluorescence intensity at 650&#xa0;nm increased with rising temperature, whereas the fluorescence intensity at 612&#xa0;nm decreased with increasing temperature. This observation is primarily attributed to Cu<sup>2&#x2b;</sup> being a tetrahedral metal ion with four coordination sites, which readily achieves coordination saturation. The resulting compounds or polymer structures exhibit stability, and the binding constant increases. Consequently, its overall structure, irrespective of its form, resembles that of a well-defined compound. Thus, its fluorescence behavior as a function of temperature can be explained by traditional molecular principles: as the temperature decreases, the fluorescence intensity increases, leading to highly efficient fluorescence quenching. Zn<sup>2&#x2b;</sup> can adopt a pentacoordinate state. The LD<sub>4</sub> molecule contains four lysine side chains, each providing two amino groups as potential ligands. Consequently, during the binding process, LD<sub>4</sub> tends to form a tetrahedral coordination structure, which cannot fully satisfy the pentacoordination requirement of Zn<sup>2&#x2b;</sup> (<xref ref-type="bibr" rid="B14">He et al., 2011</xref>). In the pentacoordinate state, Zn<sup>2&#x2b;</sup> exhibits an unsaturated coordination environment, and its structure achieves partial stability through dynamic adjustments. However, this relatively unstable configuration is prone to physical energy-dissipating processes, such as rotation, vibration, and oscillatory motions, which adversely affect fluorescence emission efficiency. When the temperature increases, the complex of LD<sub>4</sub> with zinc ions facilitates increased molecular collisions and structural reorganization, thereby transitioning the system from an unstable state to a more stable configuration. This reduction in instability leads to decreased internal energy dissipation within the molecules, which enhances fluorescence emission. Conversely, when the temperature decreases, the coordination-unsaturated state induces continuous internal mechanical adjustments within the molecules. These adjustments result in greater vibrational and oscillatory energy losses, which diminish luminescence efficiency. In conclusion, the response of the unstable structural state caused by coordination desaturation to temperature changes is opposite to that of stable structure molecules: when the temperature rises, the fluorescence signal intensifies; while when the temperature drops, the fluorescence intensity weakens.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Fluorescence spectra of LD<sub>4</sub> <bold>(A)</bold>, LD<sub>4</sub> &#x2b; Cu<sup>2&#x2b;</sup> <bold>(B)</bold>, and LD<sub>4</sub> &#x2b; Zn<sup>2&#x2b;</sup> <bold>(C)</bold> under various temperature conditions, fluorescence quenching efficiency analysis <bold>(D)</bold>, and infrared spectroscopy measurements <bold>(E)</bold>.</p>
</caption>
<graphic xlink:href="fphar-16-1626193-g003.tif">
<alt-text content-type="machine-generated">(A) Line graph showing the fluorescence intensity of LD&#x2084; across temperatures 0&#x00b0;C, 10&#x00b0;C, and 20&#x00b0;C with peaks around 700 nm. (B) Line graph showing fluorescence intensity of LD&#x2084; with Cu&#x00b2;&#x207a; at the same temperatures, with decreased peaks. (C) Line graph showing fluorescence intensity of LD&#x2084; with Zn&#x00b2;&#x207a;, exhibiting different fluorescence patterns. (D) Bar graph illustrating fluorescence quenching efficiency for LD&#x2084; with Cu&#x00b2;&#x207a; and Zn&#x00b2;&#x207a; at varying temperatures. (E) Spectra showing transmittance against wavenumber for LD&#x2084;, LD&#x2084; +Cu&#x00b2;&#x207a;, and LD&#x2084; +Zn&#x00b2;&#x207a;, highlighting differences at specific wavenumbers.</alt-text>
</graphic>
</fig>
<p>Furthermore, the infrared spectra of LD<sub>4</sub>, LD<sub>4</sub> &#x2b; Cu<sup>2&#x2b;</sup>, and LD<sub>4</sub> &#x2b; Zn<sup>2&#x2b;</sup> were recorded to investigate the changes in their functional groups in response to metal ion coordination. The results are presented in <xref ref-type="fig" rid="F3">Figure 3E</xref>. The absorption peaks observed at 964&#xa0;cm<sup>&#x2212;1</sup> correspond to the stretching vibration of -NH- in the inner ring of porphyrin; the peaks at 1,440&#xa0;cm<sup>&#x2212;1</sup> and 1,516&#xa0;cm<sup>&#x2212;1</sup> belong to the deformation vibration of -CH<sub>2</sub> on the porphyrin ring and the stretching vibration of -C&#x3d;C-, respectively; the absorption peaks at 1,674&#xa0;cm<sup>&#x2212;1</sup> and 1,598&#xa0;cm<sup>&#x2212;1</sup> correspond to the deformation vibration of -C&#x3d;O and -NH- in the amide bond. Moreover, the absorption peak at 797&#xa0;cm<sup>&#x2212;1</sup> indicated the presence of a benzene ring. In the LD<sub>4</sub> &#x2b; Cu<sup>2&#x2b;</sup> group, the disappearance of the absorption peak at 964&#xa0;cm<sup>&#x2212;1</sup> indicated the suppression of -NH- stretching vibrations. The peak at 1,107&#xa0;cm<sup>&#x2212;1</sup> was attributed to the stretching vibration of -S&#x3d;O, while the peak at 619&#xa0;cm<sup>&#x2212;1</sup> corresponds to the bending vibration of -NH- induced by the coordination of Cu<sup>2&#x2b;</sup> with the amino group (<xref ref-type="bibr" rid="B53">Zhao et al., 2019</xref>). These results confirmed successful coordination between Cu<sup>2&#x2b;</sup> and the free amino groups in the porphyrin ring. Additionally, a broad peak observed in the 3,000&#x2013;3,500&#xa0;cm<sup>&#x2212;1</sup> region suggests the presence of hydrogen bonding and possible polymer formation. The peak at 3,192&#xa0;cm<sup>&#x2212;1</sup> is associated with the -NH- vibration of secondary amine groups, whereas the peak at 1,070&#xa0;cm<sup>&#x2212;1</sup> may represent the characteristic oxidation state band of metal porphyrins formed upon coordination of Cu<sup>2&#x2b;</sup> with the -NH- group in the inner porphyrin ring. The infrared spectroscopic analysis of the LD<sub>4</sub> &#x2b; Zn<sup>2&#x2b;</sup> group revealed that the absorption peak at 697&#xa0;cm<sup>&#x2212;1</sup> was attributed to the deformation vibration of -NH- induced by the coordination of Zn<sup>2&#x2b;</sup> with -NH<sub>2</sub>. The sharp peak at 1,549&#xa0;cm<sup>&#x2212;1</sup> showed a significantly increased intensity and reduced transmittance compared to the peak at 1,598&#xa0;cm<sup>&#x2212;1</sup> in the LD<sub>4</sub> spectrum. This finding confirmed the formation of N-Zn coordination bonds due to chemical bond changes on the amino group. The peak at 1,454&#xa0;cm<sup>&#x2212;1</sup> corresponded to the symmetric stretching vibration of COO<sup>&#x2212;</sup>. Moreover, the higher transmittance of the peak at 3,427&#xa0;cm<sup>&#x2212;1</sup> compared to the peak at 3,419&#xa0;cm<sup>&#x2212;1</sup> in the LD<sub>4</sub> spectrum indicated a weakened stretching vibration of the amino group (<xref ref-type="bibr" rid="B21">Kurtikyan et al., 2014</xref>). This evidence suggested partial participation of amino groups in Zn<sup>2&#x2b;</sup> coordination, while some amino groups remained uncoordinated.</p>
</sec>
<sec id="s3-4">
<title>3.4 ROS yield of the combination of metal ions and LD<sub>4</sub>
</title>
<p>The determination of ROS yield serves as a critical indicator for evaluating the oxidative damage exerted by antibacterial agents on pathogen cells (<xref ref-type="bibr" rid="B20">Khorsandi et al., 2022</xref>). Measuring ROS yield aids in elucidating the antibacterial mechanism of aPDT, and directly reflects its therapeutic efficacy. The fluorescence spectra of DCFH-DA and the corresponding ROS yield results are presented in <xref ref-type="fig" rid="F4">Figure 4</xref>. As the concentration of Zn<sup>2&#x2b;</sup> increased, the production of ROS after LD<sub>4</sub> irradiation gradually increased. In contrast, with increasing concentrations of Cu<sup>2&#x2b;</sup>, the ability to generate ROS progressively diminished. Cu<sup>2&#x2b;</sup> induced a fluorescence quenching effect on LD<sub>4</sub>, leading to a significantly reduced ROS yield rate compared to LD<sub>4</sub> alone. At a Cu<sup>2&#x2b;</sup> concentration of 50&#xa0;&#x3bc;g/mL, the ROS production rate decreased to only 6.58% &#xb1; 0.13% of that observed with LD<sub>4</sub> alone. Conversely, the addition of Zn<sup>2&#x2b;</sup> significantly enhanced the ability of LD<sub>4</sub> to generate ROS, achieving an ROS production rate of 322.35% &#xb1; 7.30% at a Zn<sup>2&#x2b;</sup> concentration of 50&#xa0;&#x3bc;g/mL. These experimental results demonstrated that the synergistic interaction between Zn<sup>2&#x2b;</sup> and LD<sub>4</sub> significantly increased the ROS yield, enabling efficient bacterial eradication. Although the combination of Cu<sup>2&#x2b;</sup> and LD<sub>4</sub> generated less ROS, it still exhibited notable antibacterial efficacy. The relatively low ROS yield can be attributed to the formation of stable complexes between Cu<sup>2&#x2b;</sup> and the amino groups on the side chains of LD<sub>4</sub>. This interaction reduces non-radiative transitions while enhancing radiative transitions, thereby minimizing vibrational and rotational energy losses to the greatest extent (<xref ref-type="bibr" rid="B19">Kej&#xed;k et al., 2021</xref>). The significant antibacterial activity observed may result from the ability of the Cu<sup>2&#x2b;</sup>-LD<sub>4</sub> complex to promote the oxidation of bacterial cell wall lipids, which severely compromises the structural integrity of the bacterial cell wall.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Yield and changes in the levels of ROS after LD<sub>4</sub> was combined with varying concentrations of metal ions. Fluorescence spectra of DCFH-DA upon combination of LD<sub>4</sub> with different concentrations of <bold>(A)</bold> Cu<sup>2&#x2b;</sup> and <bold>(B)</bold> Zn<sup>2&#x2b;</sup>. <bold>(C)</bold> Changes in the levels of ROS after LD<sub>4</sub> was combined with metal ions. Abbreviations: <italic>C. albicans</italic>, <italic>Candida albicans</italic>; DCFH-DA, 2,7-dichlorofluorescein diacetate; <italic>Mtb</italic>, <italic>Mycobacterium tuberculosis</italic>; ROS, reactive oxygen species.</p>
</caption>
<graphic xlink:href="fphar-16-1626193-g004.tif">
<alt-text content-type="machine-generated">(A) Graph showing fluorescence intensity as a function of wavelength for various concentrations: 50, 25, 12.5, 6.25, 3.125, and 0 micrograms per milliliter. The inset magnifies the lower concentrations. (B) Similar graph with overlapping lines for each concentration. (C) Bar chart illustrating the rate of change in reactive oxygen species (ROS) for copper and zinc ions at the same concentrations, with zinc showing higher rates.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-5">
<title>3.5 TEM analysis</title>
<p>TEM analysis was further utilized to explore the mechanism underlying the synergistic antibacterial effect of metal ions and LD<sub>4</sub>. Bacterial morphological changes were examined (<xref ref-type="fig" rid="F5">Figure 5</xref>). The cell wall of <italic>Mtb</italic> contains a high concentration of lipids (<xref ref-type="bibr" rid="B5">Chen et al., 2017</xref>). The results demonstrated that H37Rv exhibited intact structural integrity, with a tightly packed cell wall, an undamaged cell membrane, and observable ribosomes in the control group. In contrast, in the Cu<sup>2&#x2b;</sup> treatment group, partial indentations were observed in the bacterial cell wall compared to the control group. Additionally, no significant differences were noted between the light and dark condition groups, suggesting that light exposure did not significantly influence the Cu<sup>2&#x2b;</sup>-induced damage to the <italic>Mtb</italic> cell wall. Bacterial deformation and cell wall indentation were observed in the Zn<sup>2&#x2b;</sup> treatment group. However, light exposure did not significantly compromise the structural integrity of the bacteria. In the LD<sub>4</sub> group, bacterial structures remained largely intact under dark condition, with no clear cell wall indentation or damage. Similarly, under light condition, the bacterial cell wall maintained its integrity. These findings suggest that under light reaction conditions, LD<sub>4</sub> does not significantly impair the viability of <italic>Mtb</italic>. In the LD<sub>4</sub> &#x2b; Cu<sup>2&#x2b;</sup> group, detachment of the bacterial cell wall from the cell membrane was observed in the dark reaction group, suggesting that the dark reaction significantly affected the structural integrity of <italic>Mtb</italic> cells. The coordination of Cu<sup>2&#x2b;</sup> with the amino groups of LD<sub>4</sub> formed a copper-ammonia complex with strong oxidizing properties, which induced the separation of the cell wall and cell membrane. Under light condition, the cell wall was severely compromised, leading to leakage of bacterial contents, which severely impaired the physiological activity of <italic>Mtb</italic> and consequently resulted in a strong antibacterial effect. In the LD<sub>4</sub> &#x2b; Zn<sup>2&#x2b;</sup> group, bacterial structures were relatively intact, and antibacterial activity was weak under dark condition. In contrast, under light condition, the bacterial cell wall exhibited damage, intracellular contents leaked out, and separation of the cell wall from the cell membrane as well as a blank region around the ribosomes were observed. Typically, hydrogen peroxide, peracetic acid, and chlorine dioxide are used as disinfectants for inactivating <italic>Mtb</italic>. However, their effective concentrations are relatively high; for example, hydrogen peroxide requires 0.8%, while peracetic acid requires 0.06%, and these agents must be maintained for 60&#x2013;90&#xa0;min to effectively kill <italic>Mtb</italic>. Chlorine dioxide requires an effective concentration of 1&#x2013;10&#xa0;g/L (<xref ref-type="bibr" rid="B37">Rutala et al., 1991</xref>). Additionally, these three disinfectants exhibit significant cytotoxicity and can cause strong irritation to the respiratory tract.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Transmission electron microscopy of H37Rv under the condition of combined use of metal ions and LD<sub>4</sub>. The scale bar represents 100&#xa0;nm.</p>
</caption>
<graphic xlink:href="fphar-16-1626193-g005.tif">
<alt-text content-type="machine-generated">Transmission electron microscopy images show bacterial cells under different conditions. Rows depict treatments: Control, Copper ions, Zinc ions, and corresponding mixtures with a compound labeled LD&#x2084;. Columns represent dark and light exposure conditions, illustrating variations in cellular structure and morphology across different treatments.</alt-text>
</graphic>
</fig>
<p>We further quantified the metal ion content within the bacteria using TEM mapping, and the results are presented in <xref ref-type="fig" rid="F6">Figure 6</xref>. Under light condition, the combination of LD<sub>4</sub> with Cu<sup>2&#x2b;</sup>/Zn<sup>2&#x2b;</sup> induced significant damage to the cell wall of H37Rv, resulting in the leakage of bacterial contents. Mapping analysis of <italic>Mtb</italic> in the combined treatment group revealed that Zn was almost undetectable in the control group, whereas Cu was only present in trace amounts within the bacteria. We observed that in the LD<sub>4</sub> combined with Cu<sup>2&#x2b;</sup>/Zn<sup>2&#x2b;</sup> group, the Mapping images of Cu and Zn elements showed a high degree of overlap with bacteria cells. Additionally, Cu and Zn were detected in the bacterial efflux contents. These findings suggest that the complexes formed by Cu<sup>2&#x2b;</sup>/Zn<sup>2&#x2b;</sup> and LD<sub>4</sub> can localize to the bacterial cell wall, cell membrane, and intracellular contents, exerting antibacterial effects via photodynamic action under 650&#xa0;nm illumination. In the LD<sub>4</sub> group, a small amount of Cu was observed on the bacterial surface, whereas Zn was scarcely detectable within the bacteria. The results of the Cu<sup>2&#x2b;</sup> group showed that there was no significant difference between the bacteria in this concentration group and those in the Control group or the LD<sub>4</sub> group. This finding may be attributed to the cooperative action of the nutrient copper sensor Mac1p (<xref ref-type="bibr" rid="B13">Graden and Winge, 1997</xref>) and the toxic copper sensor Ace1p (<xref ref-type="bibr" rid="B32">Pe&#xf1;a et al., 1998</xref>), which jointly regulate copper homeostasis in bacteria, ensuring that intracellular copper ions remain within a range that satisfies physiological activity requirements while avoiding toxic accumulation. Mapping results of the Zn<sup>2&#x2b;</sup> group demonstrated that intracellular Zn<sup>2&#x2b;</sup> levels were extremely low. Zinc homeostasis is primarily regulated by the zinc importer MtNramp1 (<xref ref-type="bibr" rid="B18">Juttukonda and Skaar, 2015</xref>) and the zinc efflux protein MtZnT1 in <italic>Mtb</italic> (<xref ref-type="bibr" rid="B10">Dow et al., 2021</xref>). MtNramp1 facilitates zinc uptake to fulfill physiological demands, whereas MtZnT1 plays a critical role in preventing cytotoxic levels of intracellular Zn<sup>2&#x2b;</sup> accumulation (<xref ref-type="bibr" rid="B42">Tejada-Jim&#xe9;nez et al., 2015</xref>). Mapping results from the Cu<sup>2&#x2b;</sup> and Zn<sup>2&#x2b;</sup> groups demonstrated that <italic>Mtb</italic> exhibited a higher uptake for copper compared to zinc. When LD<sub>4</sub> was applied alone, the corresponding TEM images revealed a modest increase in copper levels within bacterial cells. In contrast, in the LD<sub>4</sub> &#x2b; Cu<sup>2&#x2b;</sup> group, where additional Cu<sup>2&#x2b;</sup> was supplemented, TEM images indicated a significant increase in intracellular copper ion levels. In the LD<sub>4</sub> &#x2b; Zn<sup>2&#x2b;</sup> group, the intracellular Zn<sup>2&#x2b;</sup> concentration was significantly higher than that in the LD<sub>4</sub> group, the control group, and the Zn<sup>2&#x2b;</sup> group. Previous findings revealed that LD<sub>4</sub> can form complexes and nanoparticles with Zn<sup>2&#x2b;</sup>, resulting in a higher singlet oxygen yield compared to LD<sub>4</sub> alone. Under 650&#xa0;nm laser irradiation, this enhanced photodynamic antibacterial activity surpassed that of LD<sub>4</sub> alone. The increased intracellular Zn<sup>2&#x2b;</sup> levels in bacteria were found to inhibit the activity of key enzymes, induce oxidative stress, high ROS yield, and interfere with the synthesis of the bacterial cell wall, thereby contributing to its overall antibacterial efficacy. Under high concentration condition, the activities of proteins involved in maintaining Cu<sup>2&#x2b;</sup> and Zn<sup>2&#x2b;</sup> homeostasis may be inhibited, leading to excessive intracellular accumulation of Cu<sup>2&#x2b;</sup> and Zn<sup>2&#x2b;</sup>, inducing toxicity and, thereby, achieving a greater antibacterial effect.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>TEM dark-field and mapping results of LD<sub>4</sub> in combination with Cu<sup>2&#x2b;</sup> and Zn<sup>2&#x2b;</sup> against <italic>Mtb</italic>. Cu and Zn elements are indicated in blue and purple, respectively. The intensity of mapping signal represents the concentration of the element. The scale bar represents 1&#xa0;&#x3bc;m. Abbreviations: <italic>Mtb</italic>, <italic>Mycobacterium tuberculosis</italic>; TEM, transmission electron microscopy.</p>
</caption>
<graphic xlink:href="fphar-16-1626193-g006.tif">
<alt-text content-type="machine-generated">Transmission electron microscopy images show cell responses under different conditions for Cu&#x00b2;&#x207a; and Zn&#x00b2;&#x207a; treatments. The left column for each treatment shows TEM, the middle shows elemental mapping, and the right shows merged images. Conditions include Control, LD&#x2084;, Cu&#x00b2;&#x207a;/Zn&#x00b2;&#x207a; alone, and combined treatments with light/dark exposure. Differences in elemental mapping intensity are visible across conditions, indicating varying metal interactions or uptake.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-6">
<title>3.6 Cytotoxicity of the combination of metal ions and LD<sub>4</sub>
</title>
<p>Mouse embryonic fibroblast cells (3T3), human immortalized keratinocytes (HaCaT), human normal liver cells (LO2), and human bronchial epithelial cells (BEAS-2B) were selected to evaluate the cytotoxicity under the synergistic cytotoxicity of metal ions and LD<sub>4</sub> using CCK-8 assays. The results are presented in <xref ref-type="fig" rid="F7">Figures 7A&#x2013;D</xref>. At low concentrations, the cell survival rate remained relatively high. Under therapeutic dose conditions, the cell viability was maintained &#x3e;98% across all tested cell lines. However, when the concentration of LD<sub>4</sub> in combination with Cu<sup>2&#x2b;</sup> was gradually increased to 31.25 &#x2b; 12.5&#xa0;&#x3bc;g/mL, the survival rate of HaCaT cells decreased significantly to 52.43% &#xb1; 8.63%. Notably, at this concentration, no cytotoxic effects were observed in 3T3, BEAS-2B, or LO2 cells, with their survival rates remaining &#x3e;90%. The survival rate of HaCaT cells gradually increased with the increasing concentration. When the concentration reached 125 &#x2b; 50&#xa0;&#x3bc;g/mL, the survival rate increased to 75.36% &#xb1; 6.47%. The experimental results for the LD<sub>4</sub> combined with Zn<sup>2&#x2b;</sup> group revealed that HaCaT, 3T3, and BEAS-2B cells exhibited a trend consistent with that observed in the LD<sub>4</sub> &#x2b; Cu<sup>2&#x2b;</sup> group. Under therapeutic doses, the cell survival rate remained &#x3e;90%, indicating low cytotoxicity. However, at high concentrations, the cytotoxicity of metal ions combined with LD<sub>4</sub> was observed. At 62.5 &#x2b; 25&#xa0;&#x3bc;g/mL, the viability of HaCaT, 3T3, and BEAS-2B cells was lowest, at 75.13% &#xb1; 0.94%, 63.34% &#xb1; 1.34%, and 63.48% &#xb1; 0.57%, respectively. At 125 &#x2b; 50&#xa0;&#x3bc;g/mL, the survival rate of LO2 cells was lowest, at 68.89% &#xb1; 7.08%. The possible reason for the initial increase followed by a decrease in cytotoxicity with increasing concentration is that LD<sub>4</sub> forms dimers or trimers at higher concentrations, thereby reducing metal ion-induced damage to cells and resulting in lower cytotoxicity at high concentrations. To verify the conjecture, the changes in particle size under various concentration combinations were determined.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Cytotoxicity of Cu<sup>2&#x2b;</sup> <bold>(A)</bold>, Zn<sup>2&#x2b;</sup> <bold>(B)</bold>, LD<sub>4</sub> &#x2b; Cu<sup>2&#x2b;</sup> <bold>(C)</bold>, and LD<sub>4</sub> &#x2b; Zn<sup>2&#x2b;</sup> <bold>(D)</bold>, as well as the particle size determination results of the system after mixing LD<sub>4</sub> with Cu<sup>2&#x2b;</sup>/Zn<sup>2&#x2b;</sup> at different concentrations. <bold>(E)</bold> LD<sub>4</sub> concentration of 31.25&#xa0;&#x3bc;g/mL and metal ion concentration of 12.5&#xa0;&#x3bc;g/mL. <bold>(F)</bold> LD<sub>4</sub> concentration of 62.5&#xa0;&#x3bc;g/mL and metal ion concentration of 25&#xa0;&#x3bc;g/mL. <bold>(G)</bold> LD<sub>4</sub> concentration of 50&#xa0;&#x3bc;g/mL and metal ion concentration of 50&#xa0;&#x3bc;g/mL.</p>
</caption>
<graphic xlink:href="fphar-16-1626193-g007.tif">
<alt-text content-type="machine-generated">Graphs showing cell viability and size distribution. Panels A and B illustrate decreasing cell viability with increasing concentrations of copper and zinc ions, respectively, across four cell types: 3T3, BEAS-2B, HaCaT, and LO2. Panels C and D show cell viability for combined LD&#x2084; and copper or zinc ions, with various trends depending on cell type. Panels E, F, and G depict intensity versus size distributions for LD&#x2084;, LD&#x2084; with copper ions, and LD&#x2084; with zinc ions, highlighting different size profiles for each combination.</alt-text>
</graphic>
</fig>
<p>The results of particle size determination are presented in <xref ref-type="fig" rid="F7">Figures 7E&#x2013;G</xref>. Upon mixing the LD<sub>4</sub> aqueous solution with the metal ion aqueous solution, significant aggregation was observed, with a significant increase in the proportion of particles measuring &#x3e;1&#xa0;&#x3bc;m and an overall rise in average particle size. In contrast to the observations, the LD<sub>4</sub> aqueous solution exhibited less particle aggregation. Notably, most of the particulate matter was retained in a dissolved colloidal state throughout the experimental duration, as evidenced by dynamic light scattering analysis. The cytotoxicity trend observed in <xref ref-type="fig" rid="F7">Figures 7C,D</xref> may be attributed to the formation of polymers through the combination of some LD<sub>4</sub> molecules with metal ions. This process complexes the toxic metal ions, thereby reducing their cytotoxic effects and ultimately enhancing cell survival rates.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>4 Conclusion</title>
<p>In this study, we designed and validated a synergistic antibacterial strategy by combining metal ions with LD<sub>4</sub>. Our findings revealed that both Cu<sup>2&#x2b;</sup> &#x2b; LD<sub>4</sub> and Zn<sup>2&#x2b;</sup> &#x2b; LD<sub>4</sub> demonstrated significant synergistic antibacterial effects against <italic>C. albicans</italic> and <italic>Mtb</italic>. The synergy was quantified using FICI values, ranging 0.0625&#x2013;0.281, confirming a strong synergistic interaction. The mechanistic investigation revealed the distinct antibacterial pathways of LD<sub>4</sub> &#x2b; Cu<sup>2&#x2b;</sup> and LD<sub>4</sub>&#x2b;Zn<sup>2&#x2b;</sup>. Specifically, the combination of Zn<sup>2&#x2b;</sup> with LD<sub>4</sub> led to a significant increase in ROS yield, reaching 322.35% &#xb1; 7.30% of that recorded after use of LD<sub>4</sub> alone. In contrast, Cu<sup>2&#x2b;</sup> induced fluorescence quenching of LD<sub>4</sub>, which resulted in a relatively lower ROS yield. The LD<sub>4</sub> &#x2b; Cu<sup>2&#x2b;</sup> group demonstrated stronger antibacterial activity, primarily due to the physical disruption of the lipid-rich cell wall. This finding was further substantiated by TEM images showing cell wall separation and cytoplasmic leakage under dark condition. Fluorescence and infrared spectroscopy analyses demonstrated that metal coordination modified the fluorescence state of LD<sub>4</sub> and elucidated the changes in functional groups upon complexation with metal ions. Furthermore, a systematic investigation was conducted into the intrinsic molecular mechanisms underlying the variations in fluorescence intensity. Although the antibacterial efficacy was significant, under therapeutic doses, the survival rate of normal cells remained &#x3e;90%. Cytotoxicity becomes apparent only when the concentration exceeds the therapeutic range. Systematic analysis of particle size changes in both LD<sub>4</sub> &#x2b; Cu<sup>2&#x2b;</sup> and LD<sub>4</sub> &#x2b; Zn<sup>2&#x2b;</sup> combination groups revealed the concentration-dependent cytotoxicity anomaly, where elevated drug concentrations initially intensified cytotoxic effects before subsequent attenuation at higher dosage levels. In conclusion, this study elucidated the synergistic antibacterial mechanisms of metal ions (Cu<sup>2&#x2b;</sup> and Zn<sup>2&#x2b;</sup>) with LD<sub>4</sub>, confirmed their significant potential in antibacterial therapy, and presented a promising strategy for combating fungal and mycobacterial infections.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s12">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="ethics-statement" id="s6">
<title>Ethics statement</title>
<p>Ethical approval was not required for the studies on animals in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.</p>
</sec>
<sec sec-type="author-contributions" id="s7">
<title>Author contributions</title>
<p>XW: Writing &#x2013; original draft. ZQ: Investigation, Writing &#x2013; original draft. YW: Writing &#x2013; original draft, Methodology. MC: Formal Analysis, Writing &#x2013; original draft. LZ: Data curation, Writing &#x2013; review and editing. JW: Writing &#x2013; review and editing, Resources, Validation. TL: Writing &#x2013; original draft, Conceptualization, Writing &#x2013; review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by Tianjin Key Medical Disciplines (Specialties) Construction Project (grant number: TJYXZDXK-067C) and the CAMS Innovation Fund for Medical Sciences (grant number: 2021-I2M-1-015/2021-I2M-1-052).</p>
</sec>
<ack>
<p>The authors thank the Tuberculosis Precision Testing Center for providing BSL-2 laboratory facilities and <italic>Mtb</italic> strains (including standard and clinical strains), Tianjin Center for Disease Control and Prevention for supplying the <italic>C. albicans</italic> strains, and the SCICLUBS for the assistance of testing and characterization.</p>
</ack>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s10">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s12">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2025.1626193/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphar.2025.1626193/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table1.xlsx" id="SM1" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aggarwal</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mahajan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pandiya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bajaj</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Yadav</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Antibiotic resistance: a global crisis, problems and solutions</article-title>. <source>Crit. Rev. Microbiol.</source> <volume>50</volume> (<issue>5</issue>), <fpage>896</fpage>&#x2013;<lpage>921</lpage>. <pub-id pub-id-type="doi">10.1080/1040841X.2024.2313024</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baran</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kwiatkowska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Potocki</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Antibiotics and bacterial resistance-A short story of an endless arms race</article-title>. <source>Int. J. Mol. Sci.</source> <volume>24</volume> (<issue>6</issue>), <fpage>5777</fpage>. <pub-id pub-id-type="doi">10.3390/ijms24065777</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Barbara</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zimmer</surname>
<given-names>D. E. C.</given-names>
</name>
<name>
<surname>Esparza</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Alby</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bhatnagar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ferrell</surname>
<given-names>A. L.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically CLSI approved standard</article-title> in <source>CLSI document M7-A72006</source>. <edition>Seventh Edition</edition> (<publisher-name>Wayne, PA: Clinical and Laboratory Standards Institute (CLSI)</publisher-name>). <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://clsi.org/shop/standards/m07/">https://clsi.org/shop/standards/m07/</ext-link> (Accessed March 19, 2024)</comment>.</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blair</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Webber</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Baylay</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Ogbolu</surname>
<given-names>D. O.</given-names>
</name>
<name>
<surname>Piddock</surname>
<given-names>L. J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Molecular mechanisms of antibiotic resistance</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>13</volume> (<issue>1</issue>), <fpage>42</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro3380</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>H. F.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>C. Y.</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>K. F.</given-names>
</name>
<name>
<surname>Tsui</surname>
<given-names>S. K.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Structural basis of the PE-PPE protein interaction in <italic>Mycobacterium tuberculosis</italic>
</article-title>. <source>J. Biol. Chem.</source> <volume>292</volume> (<issue>41</issue>), <fpage>16880</fpage>&#x2013;<lpage>16890</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M117.802645</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collaborators</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Ikuta</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Sharara</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Swetschinski</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Robles Aguilar</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis</article-title>. <source>Lancet</source> <volume>399</volume> (<issue>10325</issue>), <fpage>629</fpage>&#x2013;<lpage>655</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(21)02724-0</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collaborators</surname>
<given-names>G. L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015</article-title>. <source>Lancet Infect. Dis.</source> <volume>17</volume> (<issue>11</issue>), <fpage>1133</fpage>&#x2013;<lpage>1161</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(17)30396-1</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cook</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>G. D.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The past, present, and future of antibiotics</article-title>. <source>Sci. Transl. Med.</source> <volume>14</volume> (<issue>657</issue>), <fpage>eabo7793</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.abo7793</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Correia</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Pimenta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Photodynamic therapy review: principles, photosensitizers, applications, and future directions</article-title>. <source>Pharmaceutics</source> <volume>13</volume> (<issue>9</issue>), <fpage>1332</fpage>. <pub-id pub-id-type="doi">10.3390/pharmaceutics13091332</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dow</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sule</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>O&#x27;Donnell</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Burger</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mattila</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Antonio</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Zinc limitation triggers anticipatory adaptations in <italic>Mycobacterium tuberculosis</italic>
</article-title>. <source>PLoS Pathog.</source> <volume>17</volume> (<issue>5</issue>), <fpage>e1009570</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1009570</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eumkeb</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Chukrathok</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Synergistic activity and mechanism of action of ceftazidime and apigenin combination against ceftazidime-resistant <italic>Enterobacter cloacae</italic>
</article-title>. <source>Phytomedicine</source> <volume>20</volume> (<issue>3-4</issue>), <fpage>262</fpage>&#x2013;<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2012.10.008</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gienger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ost</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>B&#xe4;r</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Neukammer</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Assessment of deformation of human red blood cells in flow cytometry: measurement and simulation of bimodal forward scatter distributions</article-title>. <source>Biomed. Opt. Express</source> <volume>10</volume> (<issue>9</issue>), <fpage>4531</fpage>&#x2013;<lpage>4550</lpage>. <pub-id pub-id-type="doi">10.1364/BOE.10.004531</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graden</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Winge</surname>
<given-names>D. R.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Copper-mediated repression of the activation domain in the yeast Mac1p transcription factor</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>94</volume> (<issue>11</issue>), <fpage>5550</fpage>&#x2013;<lpage>5555</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.11.5550</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Waychunas</surname>
<given-names>G. A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Coordination structure of adsorbed Zn(II) at water-TiO2 interfaces</article-title>. <source>Environ. Sci. Technol.</source> <volume>45</volume> (<issue>5</issue>), <fpage>1873</fpage>&#x2013;<lpage>1879</lpage>. <pub-id pub-id-type="doi">10.1021/es1035283</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ikuta</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Me&#x161;trovi&#x107;</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Naghavi</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Global incidence and mortality of severe fungal disease</article-title>. <source>Lancet Infect. Dis.</source> <volume>24</volume> (<issue>5</issue>), <fpage>e268</fpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(24)00102-6</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iskandar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Molinier</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hallit</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sartelli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hardcastle</surname>
<given-names>T. C.</given-names>
</name>
<name>
<surname>Haque</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture</article-title>. <source>Antimicrob. Resist Infect. Control</source> <volume>10</volume> (<issue>1</issue>), <fpage>63</fpage>. <pub-id pub-id-type="doi">10.1186/s13756-021-00931-w</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Type I photodynamic antimicrobial therapy: principles, progress, and future perspectives</article-title>. <source>Acta Biomater.</source> <volume>177</volume>, <fpage>1</fpage>&#x2013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2024.02.005</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Juttukonda</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Skaar</surname>
<given-names>E. P.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Manganese homeostasis and utilization in pathogenic bacteria</article-title>. <source>Mol. Microbiol.</source> <volume>97</volume> (<issue>2</issue>), <fpage>216</fpage>&#x2013;<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1111/mmi.13034</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kej&#xed;k</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Kapl&#xe1;nek</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Masa&#x159;&#xed;k</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Babula</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Matkowski</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Filipensk&#xfd;</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Iron complexes of flavonoids-antioxidant capacity and beyond</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume> (<issue>2</issue>), <fpage>646</fpage>. <pub-id pub-id-type="doi">10.3390/ijms22020646</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khorsandi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hosseinzadeh</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Esfahani</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zandsalimi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shahidi</surname>
<given-names>F. K.</given-names>
</name>
<name>
<surname>Abrahamse</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Accelerating skin regeneration and wound healing by controlled ROS from photodynamic treatment</article-title>. <source>Inflamm. Regen.</source> <volume>42</volume> (<issue>1</issue>), <fpage>40</fpage>. <pub-id pub-id-type="doi">10.1186/s41232-022-00226-6</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurtikyan</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Hayrapetyan</surname>
<given-names>V. A.</given-names>
</name>
<name>
<surname>Mehrabyan</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Ford</surname>
<given-names>P. C.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Six-coordinate nitrito and nitrato complexes of manganese porphyrin</article-title>. <source>Inorg. Chem.</source> <volume>53</volume> (<issue>22</issue>), <fpage>11948</fpage>&#x2013;<lpage>11959</lpage>. <pub-id pub-id-type="doi">10.1021/ic5014329</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Villaruz</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Diep</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>MRSA epidemic linked to a quickly spreading colonization and virulence determinant</article-title>. <source>Nat. Med.</source> <volume>18</volume> (<issue>5</issue>), <fpage>816</fpage>&#x2013;<lpage>819</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2692</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y. X.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Sequence-based functional metagenomics reveals novel natural diversity of functional CopA in environmental microbiomes</article-title>. <source>Genomics Proteomics Bioinforma.</source> <volume>21</volume> (<issue>6</issue>), <fpage>1182</fpage>&#x2013;<lpage>1194</lpage>. <pub-id pub-id-type="doi">10.1016/j.gpb.2022.08.006</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Global spread of carbapenem-resistant Enterobacteriaceae: epidemiological features, resistance mechanisms, detection and therapy</article-title>. <source>Microbiol. Res.</source> <volume>266</volume>, <fpage>127249</fpage>. <pub-id pub-id-type="doi">10.1016/j.micres.2022.127249</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Synthesis, characterization and <italic>in vitro</italic> photodynamic antimicrobial activity of basic amino acid-porphyrin conjugates</article-title>. <source>Eur. J. Med. Chem.</source> <volume>92</volume>, <fpage>35</fpage>&#x2013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2014.12.029</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitchell</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>T. J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Streptococcus pneumoniae: virulence factors and variation</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>16</volume> (<issue>5</issue>), <fpage>411</fpage>&#x2013;<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-0691.2010.03183.x</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitra</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>E. T.</given-names>
</name>
<name>
<surname>Neoh</surname>
<given-names>K. G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Antimicrobial copper-based materials and coatings: potential multifaceted biomedical applications</article-title>. <source>ACS Appl. Mater Interfaces</source> <volume>12</volume> (<issue>19</issue>), <fpage>21159</fpage>&#x2013;<lpage>21182</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.9b17815</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>M&#xf8;ller</surname>
<given-names>K. I.</given-names>
</name>
<name>
<surname>Kongshoj</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Philipsen</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Thomsen</surname>
<given-names>V. O.</given-names>
</name>
<name>
<surname>Wulf</surname>
<given-names>H. C.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>How Finsen&#x27;s light cured lupus vulgaris</article-title>. <source>Photodermatol. Photoimmunol. Photomed.</source> <volume>21</volume> (<issue>3</issue>), <fpage>118</fpage>&#x2013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0781.2005.00159.x</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monneau</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Arrault</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Duroux</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chirot</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mac Aleese</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Structural and dynamical insights into SilE silver binding from combined analytical probes</article-title>. <source>Phys. Chem. Chem. Phys.</source> <volume>25</volume> (<issue>4</issue>), <fpage>3061</fpage>&#x2013;<lpage>3071</lpage>. <pub-id pub-id-type="doi">10.1039/d2cp04206a</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oordt-Speets</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Bolijn</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>van Hoorn</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Bhavsar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kyaw</surname>
<given-names>M. H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Global etiology of bacterial meningitis: a systematic review and meta-analysis</article-title>. <source>PLoS One</source> <volume>13</volume> (<issue>6</issue>), <fpage>e0198772</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0198772</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="web">
<collab>Organization, W.H</collab> (<year>2014</year>). <article-title>Antimicrobial resistance: global report on surveillance</article-title>. <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications/i/item/9789241564748">https://www.who.int/publications/i/item/9789241564748</ext-link> (Accessed April 1, 2014)</comment>.</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pe&#xf1;a</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Thiele</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Dynamic regulation of copper uptake and detoxification genes in <italic>Saccharomyces cerevisiae</italic>
</article-title>. <source>Mol. Cell Biol.</source> <volume>18</volume> (<issue>5</issue>), <fpage>2514</fpage>&#x2013;<lpage>2523</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.18.5.2514</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puttaswamy</surname>
<given-names>N. Y.</given-names>
</name>
<name>
<surname>Mahanta</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sarma</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Medhi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kaid</surname>
<given-names>S. M. A.</given-names>
</name>
<name>
<surname>Kullaiah</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Structure-based biological investigations on ruthenium complexes containing 2,2&#x2032;-bipyridine ligands and their applications in photodynamic therapy as a potential photosensitizer</article-title>. <source>Chem. Biol. Drug Des.</source> <volume>102</volume> (<issue>6</issue>), <fpage>1506</fpage>&#x2013;<lpage>1520</lpage>. <pub-id pub-id-type="doi">10.1111/cbdd.14341</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>T. W.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Recent advances in the development of lipid-metal-carbon-and polymer-based nanomaterials for antibacterial applications</article-title>. <source>Nanomater. (Basel)</source> <volume>12</volume> (<issue>21</issue>), <fpage>3855</fpage>. <pub-id pub-id-type="doi">10.3390/nano12213855</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riduan</surname>
<given-names>S. N.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Recent advances of zinc-based antimicrobial materials</article-title>. <source>Chem. Asian J.</source> <volume>16</volume> (<issue>18</issue>), <fpage>2588</fpage>&#x2013;<lpage>2595</lpage>. <pub-id pub-id-type="doi">10.1002/asia.202100656</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodichkin</surname>
<given-names>A. N.</given-names>
</name>
<name>
<surname>Guilarte</surname>
<given-names>T. R.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Hereditary disorders of manganese metabolism: pathophysiology of childhood-onset dystonia-parkinsonism in SLC39A14 mutation carriers and genetic animal models</article-title>. <source>Int. J. Mol. Sci.</source> <volume>23</volume> (<issue>21</issue>), <fpage>12833</fpage>. <pub-id pub-id-type="doi">10.3390/ijms232112833</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rutala</surname>
<given-names>W. A.</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>Wannamaker</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>Inactivation of <italic>Mycobacterium tuberculosis</italic> and Mycobacterium bovis by 14 hospital disinfectants</article-title>. <source>Am. J. Med.</source> <volume>91</volume> (<issue>3b</issue>), <fpage>267s</fpage>&#x2013;<lpage>271s</lpage>. <pub-id pub-id-type="doi">10.1016/0002-9343(91)90380-g</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Setiawati</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nuryastuti</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ngatidjan</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mustofa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jumina</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fitriastuti</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>
<italic>In vitro</italic> antifungal activity of (1)-N-2-Methoxybenzyl-1,10-phenanthrolinium bromide against Candida albicans and its effects on membrane integrity</article-title>. <source>Mycobiology</source> <volume>45</volume> (<issue>1</issue>), <fpage>25</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.5941/MYCO.2017.45.1.25</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chandola</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>
<italic>Escherichia coli</italic> biofilm: development and therapeutic strategies</article-title>. <source>J. Appl. Microbiol.</source> <volume>121</volume> (<issue>2</issue>), <fpage>309</fpage>&#x2013;<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1111/jam.13078</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sia</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Rengarajan</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Immunology of <italic>Mycobacterium tuberculosis</italic> infections</article-title>. <source>Microbiol. Spectr.</source> <volume>7</volume> (<issue>4</issue>). <pub-id pub-id-type="doi">10.1128/microbiolspec.GPP3-0022-2018</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tabata</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kumamoto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nishimoto</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Ion-pair extraction of metalloporphyrins into acetonitrile for determination of copper(II)</article-title>. <source>Anal. Chem.</source> <volume>68</volume> (<issue>5</issue>), <fpage>758</fpage>&#x2013;<lpage>762</lpage>. <pub-id pub-id-type="doi">10.1021/ac950569w</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tejada-Jim&#xe9;nez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Castro-Rodr&#xed;guez</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kryvoruchko</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Lucas</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Udvardi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Imperial</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Medicago truncatula natural resistance-associated macrophage Protein1 is required for iron uptake by rhizobia-infected nodule cells</article-title>. <source>Plant Physiol.</source> <volume>168</volume> (<issue>1</issue>), <fpage>258</fpage>&#x2013;<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1104/pp.114.254672</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Timmerhuis</surname>
<given-names>H. C.</given-names>
</name>
<name>
<surname>van den Berg</surname>
<given-names>F. F.</given-names>
</name>
<name>
<surname>Noorda</surname>
<given-names>P. C.</given-names>
</name>
<name>
<surname>van Dijk</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>van Grinsven</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sperna Weiland</surname>
<given-names>C. J.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Overuse and misuse of antibiotics and the clinical consequence in necrotizing pancreatitis: an observational multicenter study</article-title>. <source>Ann. Surg.</source> <volume>278</volume> (<issue>4</issue>), <fpage>e812</fpage>&#x2013;<lpage>e819</lpage>. <pub-id pub-id-type="doi">10.1097/SLA.0000000000005790</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsolekile</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Parani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>de Macedo</surname>
<given-names>E. F.</given-names>
</name>
<name>
<surname>Lebepe</surname>
<given-names>T. C.</given-names>
</name>
<name>
<surname>Maluleke</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ncapayi</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Photodynamic therapy and antibacterial activities of a novel synthesized quaternary Zn-Cu-in-S/ZnS QDs-mTHPP porphyrin conjugate</article-title>. <source>Int. J. Nanomedicine</source> <volume>17</volume>, <fpage>5315</fpage>&#x2013;<lpage>5325</lpage>. <pub-id pub-id-type="doi">10.2147/IJN.S382302</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ward</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Hoye</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Talaat</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>The global responses of <italic>Mycobacterium tuberculosis</italic> to physiological levels of copper</article-title>. <source>J. Bacteriol.</source> <volume>190</volume> (<issue>8</issue>), <fpage>2939</fpage>&#x2013;<lpage>2946</lpage>. <pub-id pub-id-type="doi">10.1128/JB.01847-07</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>D. N.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Ribosome-targeting antibiotics and mechanisms of bacterial resistance</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>12</volume> (<issue>1</issue>), <fpage>35</fpage>&#x2013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro3155</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>One-pot fabrication of dual-emission and single-emission biomass carbon dots for Cu(2&#x2b;) and tetracycline sensing and multicolor cellular imaging</article-title>. <source>Anal. Bioanal. Chem.</source> <volume>412</volume> (<issue>27</issue>), <fpage>7481</fpage>&#x2013;<lpage>7489</lpage>. <pub-id pub-id-type="doi">10.1007/s00216-020-02882-4</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>A membrane-targeted photosensitizer prevents drug resistance and induces immune response in treating candidiasis</article-title>. <source>Adv. Sci. (Weinh)</source> <volume>10</volume> (<issue>35</issue>), <fpage>e2207736</fpage>. <pub-id pub-id-type="doi">10.1002/advs.202207736</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Mechanism and <italic>in vivo</italic> evaluation: photodynamic antibacterial chemotherapy of lysine-porphyrin conjugate</article-title>. <source>Front. Microbiol.</source> <volume>7</volume>, <fpage>242</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2016.00242</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The mechanism of metal-based antibacterial materials and the progress of food packaging applications: a review</article-title>. <source>Ceram. Int.</source> <volume>48</volume> (<issue>23</issue>), <fpage>34148</fpage>&#x2013;<lpage>34168</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceramint.2022.08.249</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname>
<given-names>I. X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>I. S.</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>C. H.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The antibacterial mechanism of silver nanoparticles and its application in dentistry</article-title>. <source>Int. J. Nanomedicine</source> <volume>15</volume>, <fpage>2555</fpage>&#x2013;<lpage>2562</lpage>. <pub-id pub-id-type="doi">10.2147/IJN.S246764</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zapun</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Contreras-Martel</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Vernet</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Penicillin-binding proteins and beta-lactam resistance</article-title>. <source>FEMS Microbiol. Rev.</source> <volume>32</volume> (<issue>2</issue>), <fpage>361</fpage>&#x2013;<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6976.2007.00095.x</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Synthesis and characterization of novel porphyrin-cinnamic acid conjugates</article-title>. <source>Spectrochim. Acta A Mol. Biomol. Spectrosc.</source> <volume>223</volume>, <fpage>117314</fpage>. <pub-id pub-id-type="doi">10.1016/j.saa.2019.117314</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>